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Zusammenfassung
Mit der Entwicklung der Gentherapie in den frühen neunziger Jahren kam die
Hoffnung auf, Krankheiten wie Krebs, die auf Gendefekten beruhen, heilen zu
können. Die größte Herausforderung besteht dabei im sicheren und effizien-
ten Transfer von Nukleinsäuren in das Innere von eukaryotischen Zellen. Da
virale Vektoren (genetisch veränderte Viren) toxisch sind und eine Immunant-
wort hervorrufen, gewinnen nicht-virale Gentransfer-Systeme (synthetische
Polymere), die diese Nachteile nicht haben, immer mehr an Bedeutung. Um
einen effizienten und sicheren Transport von Nukleinsäuren in lebende Zellen
zu erreichen wurden asymmetrische Peptid-Dendrimere niedriger Generati-
on, bestehend aus den basischen Aminosäuren Lysin und Arginin, über das
bewährte Konzept der Festphasenpeptidsynthese hergestellt. Der Mechanis-
mus der Peptid-Dendrimer/DNA (Dendriplex) Komplexbildung sowie die
Komplexstöchiometrie wurden über die Änderung der elektrophoretischen
Mobilität und durch einen Pico-Green Farbstoff Ausschluss untersucht. Die
Dendriplex -Bildung ist elektrostatischer Natur und hängt stark von dem N /
P-Verhältnis (negative zu positiven Ladungen) als auch von der Anzahl der
positiven Ladungen des Dendrimers ab. Die Peptid-Dendrimere sind in der
Lage, stabile Komplexe mit DNA unterschiedlicher Größe in einem Ladungs-
verhältnis von zwei und mehr zu bilden. Für eine wirksame Rückverfolgung
desWeges über die Zellmembran und zur quantitativenAnalyse der zellulären
Aufnahmewurden die Peptid-Dendrimere spezifisch fluoreszenzmarkiert. Das
optimaleLadungs-Verhältnis für die Transfektion und die Kapazität der Peptid-
Dendrimere als DNA Transportsystem wurden in zwei verschiedenen Zelllini-
en (NIH3T3 EpoR und HeLa) mittels konfokaler Laser-Scanning-Mikroskopie
untersucht. Eine effiziente Transfektion von Plasmid-DNA als auch von einzel-
und doppelsträngigen Oligonukleotiden verschiedener Längen mit minimaler
Zelltoxizität wurde für beide Zellinien bei einem Ladungsverhältnis von fünf
erreicht. Die intrazelluläre Verteilung der Peptid-Dendriplexe war auf das
Zytoplasma begrenzt. Die zelluläre Internalisierung der Peptid-Dendriplexes
erfolgt durch Energie abhängige Endozytose unter Einbeziehung sowohl des
Clathrin-abhängigen und Clathrin-unabhängigen Aufnahmemechanismus.
Hingegen sind das Aktin-Zytoskelett und die Lipidflößen / Caveolae nicht an
der Dendriplex Aufnahme beteiligt. Aufgrund ihres geringen pH-Werts (zwi-
schen 5,5 bis 6,5) werden fluoreszenzmarkierte Dendriplexe hauptsächlich in
den Lysosomen und teilweise in den Mitochondrien angelagert. Diese Arbeit
zeigt, dass asymmetrische peptid-basierte Dendrimere niedriger Generation
eine effiziente Transfektion in vitro von DNA in verschiedene Säuger-Zelllinien
gewährleisten. Um einen Potential als nicht-viralen Gentransfer-Vektoren für
die Genetherapie darzustellen benötigen die Peptid-Dendrimere eine signifi-
cante Verbesserung in ihrer Transfectionseffizienz.
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Abstract
The hope of a successful treatment of genetically based diseases like cancer
increased with the development of gene therapy in the early 1990’s. The major
challenge thereof is the safe and efficient transfer of nucleic acids into eu-
karyotic cells. As viral vectors (genetically modified viruses) are toxic and
immunogenic, non-viral gene delivery systems (synthetic polymers) lacking
these disadvantages continue to gain a high profile. To achieve an efficient and
safe delivery of nucleic acids into living cells, low generation asymmetric pep-
tide dendrimers comprised of the basic amino acids lysine and arginine were
synthesized using the well established solid phase peptide synthesis approach.
The mechanisms of peptide dendrimer/DNA complex (dendriplex) formation
as well as the complex stoichiometry were inspected by electrophoretic mo-
bility shift assay and a PicoGreen exclusion assay. The dendriplex formation
is of electrostatic nature and strongly depends on the charge ratio as well as
on the number of dendrimer head group charges. The peptide dendrimers
are able to form stable complexes with DNA of various sizes at a charge ratio
of two and higher. For effective tracing of the pathway through the cell mem-
brane and quantitative evaluation of cellular uptake the peptide dendrimer
was site-specifically labelled with a fluorophore. The optimal transfection
charge ratio and the capacity of the peptide dendrimers as a DNA delivery
system were examined in two different cell lines (NIH3T3 EpoR and HeLa)
by confocal laser scanning microscopy. Efficient transfection of plasmid DNA
as well as of single and double stranded oligonucleotides of various lengths
with minimal cell toxicity was achieved for both cell lines at a charge ratio
of five. The intracellular distribution of the dendriplexes was limited to the
cell cytoplasm. The cellular internalization of dendriplexes was found to oc-
cur by energy dependent endocytosis including both clathrin-dependent and
clathrin-independent uptake pathways. Furthermore, the actin cytoskeleton
and the lipid rafts/caveolae are not involved in the dendriplexe uptake mech-
anism. Due to their low pH (between 5.5-6.5), fluorescent dendriplexes are
mainly directed to lysosomes and partially to mitochondria. These studies has
demonstrated that low fluorescent labelled generation asymmetric peptide
based dendrimers can transfect different mammalian cells in vitro. To possess
a potential as a non-viral gene delivery vectors for gene therapy a significant
improvement of their transfection efficiency is needed.

„In der Ruhe liegt die Kraft”
Konfuzius
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Chapter 1
Introduction
In the last few decades cancer has become a leading cause for death in indus-
trialized countries. New innovative approaches for successful treatment of
this complex disease require a better understanding of the genes involved in
the development and growth of cancer [WZM04]. A promising tool to fight
this disease is the approach of gene therapy that involves the introduction
of genetic material into a person’s cell to fight or prevent disease. Since the
introduction of the gene therapy concept in the early 1990’s, gene delivery
vector research has entered a fast evolving era [CB08]. A major problem in
exploiting the full potential of cancer gene therapy is the lack of a safe and
efficient nucleic acids delivery system.
The efficient gene transfer to the target cells with minimal immune re-
sponses and toxicity remains one of the major challenges to gene therapists.
Therefore, the discovery and development of efficient, versatile, and safe deliv-
ery vehicles for therapeutic genes became the most critical part in the success
of gene therapy applications [Par+03]. The introduction of nucleic acids into
cells for therapeutic intervention is greatly impeded by their size and charge
and therefore requires sophisticated vectors that facilitate cellular uptake. Both
viral and non-viral vectors have been developed for this purpose, each with
their own advantages and shortcomings [DG11]. To date, the majority of per-
formed gene therapy clinical trials are based on the use of viral vectors for
gene delivery [Cav+00; KGN01]. These vectors are very effective in achieving
high efficiency for gene delivery and expression. However, the utility of viral
vectors for gene therapy is currently limited due to the induction of immune
response, oncogene transformations, pathogenic risks, the lack of selectivity
and the high cost [Dou+96; Mas+05; LH07].
Although viral vectors continue to remain the predominant mains for
therapeutic gene delivery this thesis focuses on non-viral delivery systems
which increasingly gain importance and became desirable for basic research
and in clinical settings [Mor+08]. A high uptake across the plasma membrane
1
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and an adequate release of the therapeutic DNA molecules and the nuclear
targeting is crucial for the success of non-viral vectors. A highly efficient non-
viral vector has the potential to be slightly toxic and non-immunogenic [Glo07;
SW11].
Designing a synthetic vector that incorporates the best of viral and non-viral
features requires a deep understanding of the cell’s sophisticated machinery
and the vector material’s functionality. The idea of using alternative non-viral
vectors for transfer of DNA/RNA into eucaryotic cells continues to receive a
great deal of research interest. In the last years the importance of non-viral
delivery systems has increased and therefore became a desirable alternative
for gene delivery. Although non-viral vector design greatly improved, there is
still a huge demand to enhance the transfection efficiency and level of toxicity
[NH02; Pez+12].
The aim of this work is to develop and characterize a multifunctional
and efficient non-viral DNA delivery system. A novel class of low generation
asymmetric peptide dendrimers are ideally suited for this purpose. These
new dendrimers with varying generation, branching factor and number of
positively charged head-groups are likely devoid of toxicity [SSP11] and allow
the site-specific attachment of different fluorescent dyes. The primary amine
termini of these peptide dendrimers are protonated at physiological pH and
can bind, condense and efficiently deliver the anionic deoxyribonucleic acid
molecule to a variety of cells.
These dendrimers were synthesized using the well established solid-phase
peptide synthesis (SPPS) approach and equipped with a p-nitro-2-pyridine-
sulphenyl (Npys) group to allow a specific fluorophore attachment. For ef-
fective tracing of the pathway through the cell membrane and quantitative
evaluation of cellular uptake the peptide dendrimer was labelledwith different
fluorescent dyes.
In further experiments, the mechanism of dendriplex formation as well as
the complex stoichiometry were examined by electrophoretic mobility shift
assay (EMSA) as a direct technique and a PicoGreen exclusion as an indirect
method. The optimal transfection charge ratio and the capacity of the peptide
dendriplexes as a DNA delivery system were examined in two different cell
lines.
For deeper understanding of the cellular uptake mechanism and internal-
ization of the peptide dendrimer/DNA complexes, I determine the effect of
a set of chemical inhibitors of endocytosis that inhibit specific uptake routes.
The intracellular trafficking of the dendriplexes was investigated by colocal-
ization studies with Mito- and Lysotracker respectively used as markers for
mitochondria and lysosomes.
This work is divided into three parts: The first part is an introduction into
3the existing methods for gene delivery with their advantages and shortcoming
(chapter 1). After representing the developed experiments and obtained results
(chapter 2) the employed materials and methods are described (chapter 3).
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1.1 Non-Viral DNA Delivery Systems: Advantages and
Barriers to overcome
The field of non-viral DNA delivery systems has gained increased interest over
the resent decades. It is widely believed that non-viral transfection systems
can overcome some problems inherent to current viral based DNA delivery
vectors including immune and toxic reactions [OFL05; KT06]. The advantages
associated with the non-viral vectors include their large scale manufacture,
their low immunogenic response, the possibility of selected modifications and
the ability to carry large inserts [Jon+01; Mor+08]. For efficient DNA delivery
non-viral vectors should overcome plenty of barriers existing in the process of
their biodistribution, cellular uptake, intracellular routing and nuclear target-
ing [SL00; Ama+05]. The barriers to DNA delivery can be classified in three
Figure 1.1: The trafficking and intracellular barriers on the DNA delivery
pathways: low uptake across the plasma membrane, insufficient DNA release
and lack of nuclear targeting. (1) DNA-complex formation. (2) Uptake of the
complex. (3) Endocytosis and transport to endosome. (4) Endosomal escape.
(5) Degradation. (6) Intracellular release. (7) Degradation. (8) Nuclear targeting
and entry. (9) Expression. Images are adapted from [SL00].
major group: low uptake across the plasma membrane, inadequate release of
the DNA and lack of nuclear entry (Figure 1.1).
The delivery of DNA from outside the cell to inside the nucleus is multi-
step process with low efficiency [WM03]. As a result, the number of DNA
molecules decreases at each step of its journey to the nucleus. An improvement
of the DNA delivery and dramatical enhancement of the transfection efficiency
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can be achieved through identifying and overcoming each hurdle along the
DNA entry pathway. Several non-viral gene delivery systems are under de-
velopment, with varying levels of sophistication. These systems offer great
structural and chemical versatility and possibilities for manipulation of their
properties so that the barriers for an improved gene delivery and expression
will be overcome [PL03; Lut+08; MS09]. The majority of established non-viral
vectors can be divided into two broad categories: (1) Naked DNAdelivery with
physical methods and (2) chemical methods involving DNA complexation
with cationic carriers [SDH00; NH01].
1.1.1 Physical methods
Physical methods excel in its simplicity and therefore represent the most
conceptually appealing approach for DNA delivery [MG05]. They include
physical manipulations of the cells such as micro-injection, electroporation,
sonoporation particle bombardment and laser irradiation [JT08]. Despite their
ease of use and effectiveness these methods are still highly damaging to the
cells and therefore an ineffective way to introduce DNA into cells.
Micro-injection
The most conceptually simple, and therefore appealing, approach for gene
delivery is the direct injection of naked DNA into a cell nucleus using a fine
glass needles under microscope. While this method of gene transfer is the
nearly 100%efficient, it is relatively time-consuming becausemicro-injection of
only one cell at a time can be achieved [Cap80;MG05]. On the other hand, some
recent advances in this technology utilizing automated systems have promised
to increase the speed and decrease the required complexity. Unfortunately, this
new technology is very costly. Therefore, the application of micro-injection
is not appropriate for research with large number of cells and in vivo DNA
delivery.
Electroporation and Nucleofection
Electroporation is a method of introducing nucleic acids into cells by using
high-voltage electrical pulses which will transiently parmeabilize the cell
membrane and therefore permits cellular uptake of macromolecules [Bel+91].
Exogenous DNA can be directly trapped into the cytoplasm within the cell
when the pores formed during the electric pulses close again (Figure 1.2). DNA
delivery tomammalian cells via electroporationwas first used in 1982 [Neu+82;
WN82]. Since that time, electroporation have become a widely used method
to deliver DNA to myriad cell types. This technique has been already applied
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to introduce plasmid DNA into tissues such as skin [TSK91],liver [Hel+96],
melanoma [Rol+98] and muscle [AM98].
A new aspect of electroporation is the application of extremely short
nanosecond high-voltage pulses which allow electroporation of cellular or-
ganelles without cell membrane personalization. This is only possible when
using pulses as short, such that the charging time of the cell membrane is not
reached [SBB01].
So far, electroporation is one of the most efficient gene transfer methods
with no limitation to the size of DNA that can be delivered [Geh03]. Although
its application is limited due to their high cell mortality after high-voltage
exposure and optimization difficulties [MD95].
Figure 1.2: Principle of electroporation. Rapid high-voltage current pulses
cause pores in the cell membrane which allows exogenous DNA to pass
through into the cytoplasm of the cells. Inspired by [Lin+09].
The nucleofection is a relatively new gene delivery approach combining
electroporation and specific cell-type solutions to direct delivery of DNA into
the cell nucleus [LBV07]. In contrast to commonly used non-viral transfec-
tion methods which rely on the cell division for the nuclear DNA transfer,
nucleofection provides the ability to transfect even non-dividing cells, such as
neuron and resting blood cells [Maa+04]. This method is highly applicable for
transfection of hard-to-transfect cell lines and primary cells, including human
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bone marrow [Rup03].
Sonoporation
Sonoporation uses mechanical energy in the form of ultrasound to transiently
enhance the cell membrane permeability and therefore increase the gene
delivery efficiency [DIJ+04]. The ultrasound energy produces microscopic
cavitation bubbles in the mixture of cells. These cavitation bubbles can then
implode producing a shock-wavewhile on or near to the cell membrane surface
(Figure 1.3). The tiny shock-wave produces pores in the cellmembrane allowing
DNA/RNA to freely diffuse into the cell. Even thought this technique feature
high efficiency, some disadvantages have been pointed out concerning its
limitation to a specific tissue type or anatomical region the required complex
equipment and cell damaging of the plasma membrane [MPG02].
Figure 1.3: Principle of sonoporation. Image adapted and modified from
[MPG02].
Molecular Vibration
Applying an electric-field induced molecular vibration for introducing DNA
into cells is a novel non invasive method promising high efficiency and low cell
mortality. Foreign molecules can cross cell membranes and penetrate into the
cytoplasm by eliciting vigorous resonating vibrations between molecules and
cells. In this procedure, the vibrational force is generated by two electrodes,
which are not in direct contact with the cells and do not create a current
through the cell‘s suspension during transfection [Son+04]. Transfection based
on molecular vibration has several unique and advantageous properties such
as minimal exogenously introduced cytotoxicity, cost effectiveness and high
efficiency.
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1.1.2 Chemical Methods
Chemical approaches use synthetic or naturally occurring compounds such as
carriers to deliver transgenic material into cells [GKL07]. The earliest chem-
ical methods for DNA delivery were introduced more than 40 years ago by
applying a high salt concentration and polycationic proteins to increase the
DNA entry into the cell [VP65]. These methods constitute the easiest, most
versatile, most effective and desirable way of DNA delivery. The general prin-
ciple is based on the complex formation between positively charged chemicals
and negatively charged DNAmolecules. These complexes are usually taken
up by cells via endocytotic pathways. The classification of these complexes
can be broadly made by the chemicals involved in the complex based on 2-
(diethylamino)ether (DEAE)-dextran, calcium phosphate, lipids, polymers,
proteins, dendrimers or others [10]. Even these methods are hampered by
cytotoxicity they are simple and effective and still widely used for transfection.
Inorganic Nanoparticles
Inorganic nanoparticles possess versatile properties which make them suitable
as non-viral DNA delivery vectors. These particles are widely available have
a rich functionality, good biocompatibility, potential capability of targeted
delivery and controlled release of carried molecules [Bou02; CA05]. This is
why various inorganic materials have emerged as a novel non-viral carriers in
the last decade [BBM04; Ozk04]. Promising inorganic nanoparticle delivery
systems such as gold, carbon nanotubes (CNTs), double hydroxide (LDH),
quantum dots and various oxide nanoparticles have been widely applied in
the delivery of drugs, genes, and vaccines to specific cells and tissues [Tor06].
The most probable mechanism for cellular uptake of inorganic nanoparti-
cles is the internalization via endocytosis (Figure 1.4). Many physical, chemical
and biological factors, such as particle size, surface properties and physiologi-
cal conditions can influence the cellular interaction and distribution [Oh+09].
Although inorganic nanoparticles show low toxicity, high stability and promise
for controlled delivery properties the cellular transfer efficiency with existing
inorganic nanoparticles is still relatively low at this stage [Xu+06].
Liposome-based Vectors
Cationic lipids represent a large group of synthetic vectors commonly used in
gene delivery. Liposomes have been explored as a delivery system for DNA in
the early 1979 [FFK79] and first being used for gene therapy by Felgner at al.
with the developing of the cationic lipid Lipofectin in 1987 [Fel87].
Lipofection (transfection mediated by liposomes) was then reported to
be 5 to 100 fold more efficient than the earlier DEAE (diethylaminoethylene)-
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Figure 1.4: Possible mechanisms for cell entry of inorganic nano-particles. A)
Interaction of positively charged nanoparticles with the plasma membrane, B)
Possible mechanism of cell entry; (1) Cell membrane deformation for particle‘s
take up (2) endocytosis into the cell (3) endosome breaking (4) DNA escape
and release. Images are adapted and modified from [Xu+06].
dextran and calcium phosphate transfection techniques [FR89]. Lipofectin-
DNA complexes are easy to handle and therefore became one of the first
chemical systems that could be used in animals [Rei+99].
All cationic lipids consist of thee parts: a hydrophobic lipid tail (anchor),
linker and polar head( Figure 1.5). The non polar hydrocarbon moieties of the
cationic lipids are represented by the hydrophobic anchor. Depending on its
structure there are threemajor groups of hydrophobic anchors: single-chain hy-
drocarbons, double-chain hydrocarbons and cholesterol. Double-chain hydro-
carbons are the most popular cationic lipids capable of forming liposomes by
themselves. In contrast the usage of single-chain hydrocarbons, better known
as surfactants due to their ability to form micelles in solution for gene therapy
is restricted due to the high cell toxicity [CH00]. The linker is the chemical
part between the hydrophobic anchor and the polar head. The function of
the linker is to ensure optimal contact between the cationic head group and
the negatively charged phosphates of the DNA [Duz+03]. According to the
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Figure 1.5: Example of a cationic lipid.
Figure 1.6: Lamellar and inverted hexagonal phase structure of lipoplexes.
Images are adapted and modified from [Mor+08].
number of head group charges cationic lipids can be classified in to two major
groups: (1) monovalent aliphatic lipids characterized by a single amino func-
tion in their head group and (2)multivalent aliphatic lipidswhose head groups
contain several amino functions. The length of the aliphatic chain influences
significantly the transfection efficiency. The myristoyl (C14) chain has been
reported to be optimal for transfection followed by the oleoyl (C18:1) chain
[Fel+94; Len+02]. Increasing the aliphatic chain length is known to increase
the bilayer rigidity of the resulting vesicles which make them unsuitable for
membrane fusion.
The electrostatic interactions between the positively charged head group
of the cationic lipids and the negatively charged phosphate groups of the
nucleic acid results in either lamellar or inverted hexagonal phase structure
(see Figure 1.6) [Ma+07]. The lamellar complex has a condensed globular
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structurewith DNA intercalated between the two bilayers, while the hexagonal
arrangement consists of DNA coated with cationic lipid monolayers in a two
dimensional hexagonal lattice [Kol98; Sim+01].
Figure 1.7: Mechanism of lipoplex-mediated transfection. Images are adapted
and modified from [Par+03].
The possible cellular entry mechanism of lipoplexes is thought to be the
endocytotic pathway [LS92; Fel+94], although fusion with the cell membrane
[Duz+89] or disruption of the cellmembrane have also beenproposed [Wou+95].
Once the lipoplexes are formed they fuse with the cell membrane sometimes
after interaction with surface proteoglycans and are intermediately taken up
by endocytosis (see Figure 1.7). After internalization to the endosomal system
rapid mixing of cationic liposomes and anionic endosomes disrupt the endo-
somal membrane and cause therefore the release of the contained DNA into
the cytoplasm and potentially towards the nucleus [Zel96].
There are several commercially available lipid transfection reagents such
as Lipofectamine™ 2000, Lipofectin®, FuGENE®, Effectene®, ect. which are
widely used for genetic engineering of cells [Hoe+05] and as referencematerials
in gene delivery studies for the evaluation of the performance of new gene
carriers. Although lipoplexes show a high level of transgen expression the
major challenge of most non-viral lipoplex based systems is their low efficiency
of DNA delivery and poorly understood structure of DNA-lipid complexes.
Cationic Polymers-based Vectors
Since the last three decades significant efforts have been made on development
of polymers as non-viral alternatives for gene delivery [Wag04; Nak+05; KT06].
Cationic polymers possess high density of primary amines which are proto-
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nated at physiological pH and therefore able to interact with the negatively
charged phosphate groups of DNA to form condensed structures (polyplexes)
which can enter the cell by endocytosis [Mid+09]. The advantage of the cationic
polymers over the cationic lipids is that they do not contain a hydrophobic
anchor and are completely water soluble [ER05]. Compared to cationic lipo-
somes, they form relatively small complexes with DNA [Ger+93; Pit+04]. A
broad range of polycations with different chemical compositions, number of
repeating units and architecture have been proposed for polyplex formation
[SDH00; GK01]. As a result a large number of polyplexes can be easily synthe-
sized and evaluated in order to create the most efficient system. Depending
on their nature cationic polymers can be classified into synthetic and natural
polymers. Synthetic polymers include branched and linear polyethyleneimine
(PEI), poly-L-lysine (PLL) and cyclodextrin based polycations. The natural
cationic polymers are represented by chitosan, atelocollagen and polypeptides
[Oh+06]. In contrast to cationic lipids cationic polymers form more stable
complexes with DNA than those of cationic lipids.
Major advantages of the cationic polymer-based DNA delivery are the
simplicity of the complex formation and the induced strongDNAcondensation
leading to large size reduction of plasmid in toroid or rod DNA polyplexes
and facilitate cellular uptake [Mid+09; Wan+09].
Natural Polymers
Although liposomes and synthetic polymer-based vectors are the most widely
used gene carriers for gene therapy natural polymers have been extensively
studied due to their low toxicity, biocompatibility and great stability at physio-
logical conditions [KA11]. Naturally derived systems such as chitosan, collagen,
pullan and dextran are being employed for a large number of gene delivery
applications [DL06].
Chitosan is a high biodegradable and biocompartible natural amino polysac-
charide consisting of N-acetyl-D-glucosamine and D-glucosamine units linked
by a β (1-4) glycosidig bond. Chitosan can be obtained by deacetylation of
chitin (a polysaccharide in the exoskeleton of crustaceans and insects) by chem-
ical processing (Figure 1.8). It is a week base and has an apparent pKa value of
6.5 which makes it insoluble at neutral and alkaline pH values but well soluble
in acidic solutions (pH 1-6) where most of the amino groups are protonated
[HA03]. This cationic structure provides strong electrostatic interaction with
negatively charged molecules such as DNA [RTE02]. This complex provides
protection against DNase degradation and displays significant biocompatibil-
ity [Kop+04]. The forming of chitosan/DNA complexes was first reported by
Mumper et al. in 1995 [RR95]. They found that depending on the molecular
weight and degree of deacetylation chitosan is able to complex DNA and form
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Figure 1.8: Preparation of chitosan via chitin deacetylation.
stable small (20-500 mn) particles. Further publications noted that the size of
the complexes is largely dependent on the N/P ratio ( the number of polymer
nitrogen (N) per DNA phosphate (P)) but not on the size of the plasmid DNA
[Mao+01]. The transfection efficiency of chitosan/DNA complexes depends on
the molecular weight of chitosan, on the stoichiometry of the chitosan/DNA
complex, on the serum concentration and on the pH value of the transfec-
tion medium [Fan+01; IOS01]. Polysaccharides such as chitosan are able to
incorporate the plasmid DNA into nanoparticles that can be internalized by
cells [GG04; LCS06]. The gene delivery process using these nanoparticles is
similar the one in lipolexes and in vitro delivery efficiency can be enhanced
significantly compared to naked DNA [Leo+98]. Despite chitosan is used not
only for gene delivery but also as a tool for drug delivery the mechanism of
transfection with this polymer is still poorly understood.
14 CHAPTER 1. INTRODUCTION
Synthetic Polymers
Synthetic polymers are a highly versatile group of macromolecules which
can be synthesized with various molecular weight, 3-D architecture, degree
of branching, number of repeating units and chemical composition. Several syn-
thetic polymers such as the cationic peptide poly-L-lysine (PLL) andpolyethylen-
imine (PEI) have been demonstrated to enhance DNA delivery both in vitro
and in vivo [Spa+98]. As cationic lipids and natural polymers, these synthetic
polymers bearing amino groups which are protonated at physiological pH and
therefore positively charged. The electrostatic interactions with the negatively
charged DNAmolecules result in a complex called polyplex which interacts as
a transfection unit [Oku+04]. The polyplex formation induces a strong DNA
condensation for more efficient cell uptake and protection against degrada-
tion [Kim12]. Polyplexes are usually captured by the cells and internalized
into vesicles by endocytosis whereby the polyplex uptake pathway strongly
depends on the polymer and the cell type [Mid+08].
Figure 1.9: Structure of poly-L-lysine.
The first synthetic polymer employed in gene delivery was poly-L-lysine
(PLL) (Figure 1.9). Conjugated with asialooromucoid this polymer was applied
for hepatocellular gene targeting [WW87]. The peptide structure of poly-L-
lysine is responsible for good biodegradability and low cell toxicity which is
a big advantage for in vivo applications. PLL is one of the most used cationic
polymers forDNAdelivery [Wol+99]. The complex formation betweenPLL and
DNA is based on electrostatic interactions. Having a low molecular weight (
less than 3 kDa) poly-L-lysine is not able to form stable polyplexes, furthermore
due to its high molecular weight PLL is more suitable as a gene delivery vector
[Wol+99]. The PLL/DNA complexes are internalized into cells via endocytosis
but their transfection efficiency is weak. A possible explanation can therefore
be the lack of amino groups allowing endocytosis as well as the stronger
electrostatic binding between DNA and these polycations which will hamper
the DNA release at the appropriate stage [MKK02].
Polyethylenimine (PEI) have been used in the chemistry for many years, but
have only recently been introduced as gene delivery vectors[Bou+95; BZB96;
Fer+97; Che+98]. PEI is a versatile polymerwhich plays an important role in the
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non-viral gene delivery. It can be synthesized in various length, be branched or
linear and modified with different functional groups (Figure 1.10) [GWM99].
The PEIs polymers are a widely used class of cationic polymers containing
Figure 1.10: Chemical structures of the linear and branched polyethylenimine
(PEI).
many protonable amino groups, leading to a high cationic charge density at
physiological pH. As a consequence these polymers are able to successfully
complex and condense nucleic acids into nano-scale particles by electrostatic
interactions between the positively charged amino groups of the PEI and the
negatively charged phosphate groups of the DNA or RNA [Ogr+99; Gur07].
The route of endocytosis has been identified for PEI polyplexes internalization.
Overall, it appears that these polyplexes can be taken up both by the clathrin
dependent pathway (CDE) and a clathrin independent pathway. These cell
entry mechanisms are not exclusive and can occur simultaneously in the same
cell [GDP06; Mid+08]. Linear, low molecular weight PEI are thought to be the
most efficient in transfection and the least cytotoxic [Bre+05]. Because of non-
protonated amines with different pKa values PEI exhibit a buffering effect in a
wide range of pH levels. This unique property enable PEI polyplexes to escape
from the endosomes due to themechanism known as the "proton sponge effect"
releasing nucleic acids into the cytoplasm [Bou+95; Son03; Oh+09]. Despite the
numerous advantages of PIE as a non-viral vector for gene delivery, a major
problem is the appreciable cytotoxicity with increasing molecular weight
and branching [Tho02]. For reducing cell toxicity induced by high molecular
weight branched PEI and increasing nuclear resistance of the polyplexes, a
wide range of polyethylene glycol (PEG) (Figure 1.11)moieties were introduced
to PEI for design of block copolymers [Ahn+02; Mao+06]. In these copolymers
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Figure 1.11: Structure of polyethylene glycol (PEG).
the hydrophilic nature of PEG reduces the toxicity of PEI and improves the
poor solubility of the PEI polyplex. Further on the PEG moieties can form
a shielding layer and protects the PEI/DNA complex against degradation
[Fis+02]. Although several strategies have been explored for improving the
efficiency of gene delivery with lipoplexes and polyplexes the low capacity of
DNA escape from the endosomes is regarded as the major limitation factor.
1.2. DENDRIMERS AS A NON-VIRAL VECTORS 17
1.2 Dendrimers as a Non-Viral Vectors
The classical synthetic polymers used for gene and drug delivery have some
disadvantages like polydispersity (they have undefined molecular weights)
and difficulties in the reproducibility of their formulations. Dendrimers are
unique macromolecules with highly branched symmetrical polymeric struc-
tures, nano-scale in size and layered architectures which provide a high degree
of surface functionality and versatility. They posses a well-defined 3D archi-
tecture, monodispersity (basically meaning they are consistent in size and
form) and specific molecular weight which makes them attractive molecules
to be used in gene delivery [Tom+85]. Compared to the traditional synthetic
polymers that trigger a great interest in the second half of the last century, den-
drimers are relative newcomers. Nevertheless, their special unique architecture
have made these highly branched mono-disperse macromolecules the focus
of intensive research over the past three decades [MKK02]. Key properties in
terms of the potential use of dendrimers in drug and gene delivery are defined
by the high density of terminal groups and the easily performable synthesis of
a broad range of molecules with different functionalities. Since their introduc-
tion PAMAM (polyamidoamine) and other dendritic polymers have gained
greater popularity as gene delivery systems because of their versatility and
simplicity in transfection [Yoo00; MGJ09; WSY11].
1.2.1 Molecular Structure and Synthesis
Dendrimers from Greek "dendron" tree and "meros" part are repetitively bran-
ched molecules consisting of a central core and of a different number of highly
branched "arms" in a spherical three-dimensional morphology (Figure 1.12).
Dendritic structures form a new polymer class called "cascade molecules"
were first reported by Vögtle and co-workers in the end of the 1970s and fur-
ther developed by Thomalia and Newkome [Ego78; Tom+85; Tom+86; G R85;
Geo86]. The first synthesised dendrimers were polyamidoamines (PAMAMs)
dendrimers as well known as starburst dendrimers [Alp91]. The dendrimer
structure is based on a core which valency dictates the number of linked den-
drons and the overall symmetry of the molecule. The dendron synthesis is
followed by covalent coupling of branching units. With each repetition of the
reaction a new layer called generation is added to the structure. Dendrimers
of lower generations (0, 1, and 2) have an asymmetric shape and possess more
open structures as compared to higher generations [Gab92]. Dendrimers of
higher generation adopt a globular structure usually have a high peripheral
density and low density at the centre cavities which allows the accommodation
of cargo molecules [KB01].
The two main dendrimer synthesis strategies are based on a stepwise
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Figure 1.12: Structural elements of PAMAM dendrimers [LMG12].
synthesis using either divergent or convergent approaches [Hod93]. By the
divergent synthesis strategy the dendrimer grows outwards starting from a
multifunctional core molecule (Figure 1.13). The core molecule reacts with
monomer molecules containing one reactive and two dormant (not active)
groups forming the first generation dendrimer. Then the new periphery of the
molecule is activated for reactions with new monomers. This process is then
repeated for several generations and the dendrimer formation occurs step by
step [Hod93]. When reaching a critical branched state dendrimers cannot grow
further because of a lack of space. This is called the "starburst effect" [Mar99].
The divergent approach is very successful for the synthesis of large quan-
tities of dendrimers. Some disadvantages of the divergent approach are the
structure defects due to side reactions and incomplete reactions of the end
groups. For preventing side reactions and to force completion a large excess of
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Figure 1.13: Divergent dendrimer synthetic strategy. Images are adapted and
modified from [Hod93].
reagents is required which can cause remarkable difficulties in the purification
of the final product.
Figure 1.14: Convergent dendrimer synthetic strategy. Image adapted and
modified from [Hod93].
The convergent synthesis approach was developed in order to overcome
the disadvantages of the divergent synthesis method [Tom+85; HF90]. The
dendrimer synthesis here starts from the end groups and progress inwards
in a stepwise processes in which two or more branch subunits react with a
single joining unit which caries two or more active sides and a distal inactive
side. The product is a new larger branch subunit which can further react with
a joining. When the growing branched polymeric dendrons have reached the
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desired size, they are attached to a multifunctional core molecule to yield
the dendrimer (Figure 1.14). The convergent synthesis approach have several
advantages such as easy purification of the product and minimal occurrence
of defects in the final structure. Furthermore it is possible to create a versatile
dendritic structures by precise placement of various functional groups at the
periphery of the macromolecule. The convergent approach does not allow the
formation of dendrimers higher generations due to steric problems occurring
in the coupling reactions of the dendrons and the core molecule.
1.2.2 Physicochemical and Biological Properties
Because of their unique molecular architecture, dendrimers show some signif-
icantly improved physical and chemical properties which make them interest-
ing for drug and gene delivery applications. When compared to traditional
linear polymers dendrimers do not show a linear increase of the intrinsic solu-
tion viscosity with mass but shows a maximum at the fourth generation and
then begins to decline [Mou+92; BR96]. This phenomenon can be explained
by the generation dependent dendrimer shape changes. A lower generation
assumes a more open planar shape, on the other hand a higher generation
tends to form a more compact spherical structure [BJM99].
The unique dendrimer structure is responsible for the highest molecular
density at the periphery of the dendrimer where the largest number of surface
functional groups reside (Figure 1.15). Eventual back-folding of the terminal
branches into the core can influence the true dendrimer shape and leads to
a more uniform or even inverse density profile [Cha+01]. Dendrimer confor-
mation in solution is also highly dependent on the nature of the solvent. For
example in "good solvents" such as water (polar) or chloroform (acidic) den-
drimers display an expanded conformation and a folded inwardly crowded
conformationwhen exposed to "bad solvents" like benzene (non polar) [Rie+01;
Jon+03].
The presence of numerous terminal surface groups facilitate the inter-
action with solvents, surfaces or other molecules and therefore makes the
dendrimers highly soluble and reactive [Mat98]. The dendrimers solubility is
strongly dependent on the nature of the surface groups. Dendrimers contain-
ing hydrophilic terminal groups are mainly soluble in polar solvents, while
dendrimers with hydrophobic end groups are most soluble in non-polar sol-
vents. On the other hand the outer shell of higher generation dendrimers is
responsible for the high molecular density of the surface which provides a
barrier that can create internal cavities within the dendrimer core which give
rise to encapsulate guest molecules in the macromolecular interior [Alp91]
(Figure 1.16).
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Figure 1.15: Dendrimer conformation. Images are adapted and modified from
[DUS05].
Figure 1.16: Schematic representation of a dendritic box with encapsulated
guest molecules. Images are adapted and modified from [ME09].
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The dendrimers multivalency is of general importance for biological appli-
cations. Diverse interactions between surface amines and nucleic acid phos-
phates are of crucial importance for the formation of DNA-dendrimer com-
plexes [AJ96; Mat98]. Furthermore, the multiple surface groups can be easily
derivatized with a large number of chemical groups to modify the dendrimer’s
properties.
Due to the growing interest in using dendrimers in biomedical appli-
cations their biological properties becomes crucial. Dendrimers consisting
free of amino groups at the periphery (e.g., amine terminated PAMAM and
polypropylene-
imine (PPI)) are reported to be generally haemolytic and cytotoxic. Neverthe-
less, compared with some of the commonly used transfection reagents, in
particular cationic polymers of higher molecular weight such as PEI (600-1000
kDa), PLL (36,6 kDa) or DEAE-dextran (500 kDa) dendrimers have been found
to be relatively non-toxic [Fis+03]. Their toxicity is both dependent on the
concentration and on the generation number [RBZ96; Wil+98]. PAMAM and
PPI dendrimers are extremely toxic to red blood cells causing their rupture
by membrane proteins interactions and changes in the protein conformation
even at only low concentration [Mal+00; Dut+06; Dut+07].
Since dendrimer cytotoxicity is directly attributed to the number of terminal
amino groups and the positive charge density, masking of these groups by
surface fictionalization can lead to reduced toxicity [Dut+08]. By considering
the general biocompatibility of dendrimer based gene delivery systems it is
necessary to differentiate between interactions and effects of the free dendrimer
and those related to the whole delivery system.
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1.2.3 Dendrimer-Nucleic Acid Interaction and Mechanistic
Aspects of Dendrimer Transfection
A wide range of polyamidoamine (PAMAM) and phosphorous containing
dendrimers have been extensively studied as gene delivery systems [AJ96;
BKB97; Tot99; Hud+99; Mam+99]. Dendrimers interact with many different
forms of nucleic acids such as DNA, RNA, and oligonucleotides. The complex-
ation process between dendrimers and nucleic acids does not seem to differ
fundamentally from other polymers with high charge density [AJ96].
The interaction of the dendrimers with the nucleic acids is based on elec-
trostatic interactions and lacks any sequence specificity [TS97; CTT00]. During
the complexation process the extended plasmid DNA configuration changes to
a more compact configuration. A local charge neutralization with the cationic
dendrimer amines and the anionic nucleic acid phosphate leads to the forma-
tion of dendrimer-DNA complexes (dendriplexes) which protect the nucleic
acid from degradation.
The morphology of the DNA-dendrimer complex is strongly dependent on
the stoichiometry and concentration of the DNA phosphates and dendrimer
amino groups as well as on the solvent properties (e.g. salt concentration, pH
and buffer strength) [CTT00]. The medium in which complex formation occurs
does not only affect their nature but also modifies other properties and even
influences in vivo stability [Kab+00].
PAMAM dendrimers are thought to bind DNA at a 1:1 charge ratio of
primary amine to phosphate. These dendrimer to DNA ratios are almost not
perfect whereas more stable and efficient complexes tend to be formed only at
higher dendrimer to DNA ratios.
The number of surface amino groups involved in the DNA binding doubles
with each increasing dendrimer generation. This also affects the nature of
complexes formed by the dendrimers different generations. In contrast to the
higher generation dendrimers will stronger bind DNA, recent studies have
shown that smaller dendrimers (PAMAMG2), which do not induce a DNA
wrap around may have a stronger binding to DNA than the larger PAMAM
G6 dendrimers [Ott+00]. On the other hand the higher generation dendrimers
are able to produced larger soluble dendriplexes because of their ability to
form net positive charged "over stoichiometric" complexes [Kab+00].
Initial studies of DNA complexes formed with PAMAM dendrimers re-
ported of a similar morphology to complexes formed with poly-lysine and
polyethylenimine. Although, poly-lysine and intact PAMAM dendrimers of
higher generation have a disposition to form clusters whereby the complex
size tends to decrease with increasing polymer size [Bie+99; Abd03].
The mechanistic aspect of transfection using dendrimers is quite com-
parable to other polymeric transfection agents. The attachment of cationic
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dendriplexes to the cell membrane is in general based on electrostatic inter-
actions between the positively charged complex and negatively charged cell
surface groups. Then the complex is taken up by endocytosis. The efficient
endosomal escape mechanism plays an important role for the trafficking to the
cytosol and finally into the nucleus [Hon+04]. Cell membranes contains many
lipids (glycerolipids, cholesterol) and proteins which are essential for their
physical properties. Cholesterol and membrane rafts are strongly involved in
the dendriplex-internalization and depletion of plasmamembrane Cholesterol
profoundly effects the gene delivery mediated by dendriplexes [NWS01].
Once internalized into the cell cytoplasm the release of dendriplexes by
the endosomes has been attributed to the protonation of the internal tertiary
nitrogens by endosomal protons. The high buffering capacity of the dendrimer
leads to a decelerated acidification of the endosome, an increased accumulation
of Cl− and induces a swelling of the endosome which facilitate the escape of
the DNA to the cytoplasm [GWM99].
The critical final step in the transfection process is the transfer of DNA from
the cytoplasm into the nucleus. Fluorescence microscopy studies of Oregon
green conjugated PANMAM dendriplexes suggest that the dendrimer itself
has the ability to accumulate partially in the nucleus [Hoo00]. However, the
major difference between lipidic and synthetic polymer gene delivery systems
is their intracellular process. For lipid-based systems the dissociation of the
complex at endosomal level is essential for their activity, polymeric systems
on the other hand appears to have some activity even when still complexed.
1.2.4 Peptide Dendrimers
Dendrimers containing a peptide branching core or/and peripheral peptide
chains are defined as "peptide dendrimers" [ST02]. The family of the peptide
dendrimers can be calcified into three major categories: (1) "grafted" peptide
dendrimers carrying peptides only as surface functionalities, (2) peptide den-
drimers composed completely of amino acids, (3) dendrimers utilizing amino
acids in their core and surface functional groups but without haven a peptide
branching units. Similar to PAMAM dendrimers, peptide dendrimers can be
synthesized either the divergent or the convergent synthesis approach (see also
Figure 1.13, Figure 1.14). A wide range of advantages for the synthesis of large
libraries of peptide dendrimers with various properties and fictionalizations
offer the solid-phase peptide synthesis (SPPS) approach [Mer63; Mer85]. This
method enables rapid synthesis of peptide dendrimers various generations
with a high purity and yield [AS89].
The peptide dendrimers show better water solubility, higher stability
against proteolysis and less toxicity to human cells that their polymeric ana-
logues [ZT97; MGJ09]. Virtue their dendritic architecture, excellent biocompat-
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ibility and low cell toxicity peptide dendrimers constitutes a very promising
vehicles for biochemical and biomedical applications such as use as biomedical
diagnostic reagents, proteinmimetics, anticancer and antiviral agents, vaccines
and drug and gene delivery systems [Kas+02; Luo+11].
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1.3 Methods for Dendriplex Characterization
Since their first synthesis in the late 1970’s dendrimers have been extensively
studied and a wide range of application in biology and medicine have been
established [Tom+85]. Dendrimers have been shown to exhibit low cytotoxicity
and to be high efficient carriers for the delivery of nucleic acids and short
oligonucleotides which make them a very promising tool for gene transfer
[MSS98; BCH06; KB07]. Dendrimers are able to form complexes with DNA on
the basis of electrostatic interactions between negatively charged phosphate
groups of the nucleic acid and protonated (positively charged) amino groups
of the polymers. Such complexes are called dendriplexes by analogy with
polyplexes (polymer-nucleic acid complex) and lipoplexes (liposome-nucleic
acid complexes) [EBD05].
Charge neutralization of both component increase the net positive charge
of the complex which results in significant changes in the physiochemical and
biological properties of the complex. Many different techniques have been
developed to describe and characterize the dendrimer-DNA complexes [SPB09;
Shc+10]. They can be general divided into two main groups: direct and indi-
rect approaches. With direct techniques such as electron microscopy, atomic
force microscopy (AFM), optical tweezers, radioimmunoassy and gel elec-
trophoresis we are able to directly observe dendriplexes and distinguish them
from pure dendrimers and nucleic acids. The indirect techniques comprise
absorbance, linear and circular dichroism, fluorescent methods, calorimetry,
electron paramagnetic resonance and others. In this indirect methods, the
parameters of a solution containing all the components are measured and
compared to the parameters of a complex and those of the pure components
[SPB09]. Used in concert, these techniques contribute complementary informa-
tions to the description of the overall architecture of dendrimer-nucleic acid
complex [LPC92].
In this work I chose electrophoretic mobility shift assay (EMAS) as a di-
rect technique and a PicoGreen assay as an indirect method for dendriplex
formation and stoichiometric examination as well as a dendrimer fluorescent
labelling for the dendriplex cellular uptake studies.
1.3.1 Electrophoretic Mobility Shift Assay (EMSA)
The electrophoretic mobility shift assay (EMSA) is a very sensitive and rapid
method to detect protein or polymer nucleic acids interactions [Fri89]. Themain
principle of this method is based on the observation that the electrophoretic
mobility of a dendriplex (almost neutral or positively charged complex) is
typically less than that of free nucleic acid. In the assay, solutions of dendrimer
and DNA are mixed and subjected to agarose or native polyacrylamide gel
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electrophoresis (PAGE) to separate dendriplex from the faster migrating free
DNA as illustrated in Figure 1.17. So the dendriplex migration will be retarded
or stopped. However, the mobility shift assay can be used for qualitative
Figure 1.17: Schematic representation of the principle of the electrophoretic
mobility shift assay (EMSA). Mixtures of nucleic acids and dendrimers are
separated according to their size and charge by electrophoresis. An agarose or
polyacrilamide gel acts as a retarding medium when the negatively charged
molecules (free DNA) migrate towards the anode.
purpose. Although, under appropriate conditions this method can provide
quantitative informations for the determination of the binding stoichiometry,
affinities and kinetics [Eis71; Fri89; Sch07].
The advantages of the mobility shift assay lies in its simplicity and robust-
ness to accommodate a wide range of binding conditions. Different sizes of
nucleic acids (ranging from short oligonucleotides up to several thousand base
pairs (bp)) [Fri89; Mel+08] and structure (single-stranded(ss), double-stranded
(ds) nucleic acids as well as small circular DNA) [A N88] can be used in this
assay. The assay works well with both highly purified proteins and crude cell
extracts. These capabilities account in large part for the continuing popularity
of the assay.
On the other hand EMSA has a few disadvantages. The most important
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limitation is the fact that samples are not at chemical equilibrium during the
electrophoresis step. Rapid dissociation during electrophoresis can disturb
the complex detection [FL94]. A second important limitation of the EMSA
is that the electrophoretic mobility of a complex depends on many factors
and the observed mobility shift does not provide an exact measure of the
molecular weights or identities of the components present in the complex
[Ada07]. Detection of dendrimer-DNA complexes within a gel electrophoresis
depends critically on two factors: the resolution of the complexed to free
nucleic acid and the stability of complexes within the gel matrix. In addition,
the significance of detectable complexes is strongly dependent on the specificity
of the involved interactions.
The use of radioisotope-labelled DNA make this assay highly sensitive
and allows a successful performance even at low protein and nucleic acid
concentrations (0.1 nm or less) and small sample volumes (less than 20µl). In
order to avoid dealing with radioactivity I make use of fluorescently labelled
DNA instead of the standard radioisotope-labelled ones and visualize it with
a gel scanner.
1.3.2 Ethidium Bromide and fluorescent dye intercalation assays
Fluorescent probes which can interact with nucleic acids gain an increasingly
important role in biophysical studies, in a variety of biomedical assays and
bioanalytical techniques. The basic principle of this assays is the intercalation
of fluorescent dyes (ethidium bromide (EB), PicoGreen (PG) [Joe+03; Cho+04;
Kim+07], GelStar [OSN07], Hoechst [Cho+06]) in to double-stranded DNA
or RNA. The fluorescent dye occupies an effective binding site for several
base pairs (for EB 2-4 bp). This binding increases significantly the fluores-
cence activity of the intercalator and causes a blue-shift in its emission maxim
wavelength. In the presents of compounds with higher affinity to DNA (den-
drimers) the intercalator dye is then displaced and its fluorescence quenched
[Kla+06; Ped+09]. Fluorescence typically occurs from aromatic molecules. For
this reason fluorescent dyes for example Atto 655 (Figure 1.19) are often organic
molecules containing conjugated pi-bond systems. The possible transitions
between states of different energy and spin are illustrated on Figure 1.18 a so
called Jablonski diagram. Several processes can occur by light absorption; a
fluorophore is exited from a lower energy level to higher vibrational level of
S1 or S2. Once an electron is excited, there are a multiple ways that energy can
be dissipated, the molecules rapidly relax to the lowest vibrational level S1
in a process called internal convention (IC). Internal convention (IC) is non-
radiation transition between the same multipletts (S2 → S1). After internal
convention normally vibrational relaxation happens. This relaxation occurs
between vibrational levels, so generally electrons will not change from one
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Figure 1.18: Jablonski diagram a schematic representation of the principle of
fluorescence. Electronic ground State S0, singlet excited states Sn and triplet
excited states Tn along with possible transitions. Absorption A, Fluorescence F,
Phosphorescence P, Vibrational Relaxation VR, Internal Conversion IC, Inter
System Crossing ISC.
electronic level to another through this method. The fluorescence emission
results then from the lowest vibrational state S1.
If molecules in the S1 state undergo spin conversion to the first triplet state
T1 the emission from this state phosphorescence is generally shifted to longer
wavelength(lower energy). This process is called inter-system crossing (ISC).
The direct radiative transition from an excited triplet state to a singlet ground
state (T1 → S0) is phosphorescence (P) [JR 06].
Due to the vibrational relaxation the energy of the emission is less than
that of absorption. Indeed fluorescence occurs at lower energies or longer
wavelength (see Figure 1.19). This phenomenon is called Stokes-shift named
after Sir. G. G. Stockes who first observed it in 1852 [Sto52].
Ethidium bromide (EB) is one of the best known and effective intercalating
agents for nucleic acid stain commonly used in the molecular biology to study
the binding properties of other species to DNA. Ethidium bromide a positively
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Figure 1.19: (a) Molecular structure of Atto 655 adopted from Sigma-Aldrich
(b) Normalized absorption and emission spectra of Atto 655.
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Figure 1.20: (a) Ethidium bromide structure (b) Process of intercalation with
DNA.
charged planar aromatic dye which is able to bind to DNA by intercalating be-
tween the base pairs (Figure 1.20) [Sae84; Tur+12]. The binding of this pigment
to double-stranded DNA causes stretch of double helical structure and greatly
enhances its fluorescence intensity and lifetime (the average time the molecule
stays in its excited state before emitting a photon) which is the base of its use
as a stain of DNA in gels [OK77; TL82; BC01]. The high affinity of ethidium
for DNA duplex is based on electrostatic interactions [TJS77; Med+99; Sho07].
The majority of the carbon and hydrogen atoms in this dye have a relatively
high electron densities which will exhibit energetically favourable pi-stacking
interactions with the base pairs of the DNA [SLH02; Sis+05; LSL07]. The partial
positive charge of the exocyclic amines is important for mediating electrostatic
and hydrogen bonding attraction with the negatively charged DNA phosphate
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groups (see also Figure 1.20(b)).
Figure 1.21: (a) Structural elements of the PicoGreen molecules responsible for
the interaction with DNA (b) Schematic model of the PG/DNA complex.
Compared to ethidium bromide PicoGreen is a relatively new but very
prominent fluorescent dye introduced as a DNA intercalator into biomedical
research nearly a decade ago [ACE96]. PicoGreen is a very sensitive fluorescent
dye with very low quantum yield which enables the detection of as little as
25 pg/ml of double-stranded DNA (dsDNA) [Sin+97]. Due to the dramatic
increase in fluorescent emission upon interaction with double-stranded DNA
(dsDNA) PicoGreen have been successfully used for DNA quantification in
solution and gels even without a detailed knowledge of its spectral properties
and mechanism of nucleic acid binding. The chemical structure of PicoGreen
(Figure 1.21(a)) was only recently determined by a combination of mass spec-
troscopy and NMR techniques [Zip+04]. Pico Green is a cyanine dye which
not only strongly binds to highly polymeric DNA but also to short duplexes <
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20 bp.
Recently Dragan et. al [Dra+10] have proposed a model explaining the
PicoGreen/DNA complex formation (Figure 1.21(b)). They suggested that
three structural elements of the PGmolecule are responsible for different types
of interactions with DNA: the benzo-thiazol and phenyl-quinolinium systems
as well as the dimethylaminopropyl chains. The quinolinium group of the
fluorescent prone intercalates into the DNA with a binding site size of nearly
4 bp ∼ 13 length [Cos+01]. This intercalation is additionally stabilized by van
der Waals interactions with the DNA bases. The benzo-thiazol, that carries one
localized positive charge is responsible for the electrostatic interaction with
the negatively charged phosphate groups of the DNA. Having in mind the
covalent binding to the quinolinium group and the electrostatically interaction
with the DNA phosphates it is to expect that the thiazol binds fixed on the
DNA. This conformation leads to strong stabilization of the whole benzo-
thiazol/quinolinium system in the preferred conformation. As a consequence
in complex with ds DNA, PG exist in a well defined conformer which exhibit a
single-exponential fluorescence decay function, i.e high values of the lifetime
and quantum yield [Dra+10].
By using EB and PG it is possible to estimate the dendriplex formation
and calculate the DNA/dendrimer charge ratio [TS97] as well as to measure
the association constants and the number of binding canters [CTT00; Fan+08].
The analysis can be performed on the basis of the fluorescence intensity or
maximum emission wavelength changes.
1.3.3 Cellular Uptake and Transfection Efficiency
Understanding the pathway of dendriplex cellular uptake and the mechanism
of transfection via dendriplexes is essential for the rational design of efficient
dendrimer-based gene delivery devices. Dendrimers are reported to enter
the cells by energy-dependent endocytosis [SJD07]. The surface functionality
and charge density of the dendrimers influence their cellular uptake and
subsequent transfection efficiency [Per+08].
Dendriplexes cellular uptake can be estimated by radioactive of fluorescent
labelling of the dendrimer or/and the nucleic acid [Shc+10]. For performing
the radioactive labelling of a plasmidDNAa 32P isotope is used. Thismethod is
fast, sensitive and highly quantitative method for measuring total DNA uptake
in cells [Dai+11]. Nevertheless, handling with radioactivity is still difficult and
harmful as well as non-specific binding of labelled dendriplexes to the surface
are the bottleneck of this method.
To avoid handling with radioactivity and obtain more specific information
about the dendriplex uptake and intracellular trafficking mechanism I used
fluorescent labelled dendrimer and DNA. Fluorescence and its distribution
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within the cells were then examined using a laser canning microscopy. The
cell fluorescence was analyzed and quantified using the public domain ImageJ
software.
Chapter 2
Experiments and Results
The goal of this chapter is to describe the experiments and both to explain
and interpret the main results of this work. The first part of the chapter refers
about the synthesis of a novel class of low generation peptide dendrimers,
their specific fluorescent labelling and studies of complex formation between
these dendrimers and DNA strands of different length. In the second part the
capacity of the peptide dendriplexes as a DNA delivery system as well as their
cell entry mechanism and intracellular distribution in two different cell lines
are illustrated in detail.
2.1 Preparation of the Peptide Dendrimers
A novel class of peptide dendrimers with varying generation, branching fac-
tor and number of positively charged head-groups were designed in the Dr.
Parekh lab at the Queensland University in Brisbane, Australia [Par+06]. Their
head groups comprised of basic amino acids Lysine and Arginine are pos-
itively charged at physiological pH and will enable complexation with the
anionic DNA sequences of interest. I used dendrimers with significantly lower
head group charges, i.e. 4+ and 8+, because dendrimers possessing large num-
bers of amine groups (> 32) on their surface have been shown to be highly
cytotoxic [RBZ96] which is a significant downfall to their in vivo application.
For the synthesis of the 8+ Cys(Npys)Arginine [8+(Arg)4-(Lys)3-(Gly)2-(Lys)-
(Cys-Npys)-Gly-NH2] (Np4) (structure see Figure 2.2) peptide dendrimer I
applied the well-established solid phase peptide synthesis (SPPS) developed
by Merrifield [Mer63; Mer85]. The basic concept of this strategy is the growth
of a peptide chain, generally from the C-terminus, on an insoluble polymeric
support (Figure 2.1). The reactions are driven to completion by the use of
large excesses of reagents. I performed the synthesis of the Np4 peptide den-
drimer on a 0.7 mmol rink amide resin following the stepwise synthesis which
35
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Figure 2.1: Solid phase peptide synthesis (SPPS) principle. Inspired by [Cha04].
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involves the successive addition of Fmoc (9-fluorenylmethyloxycarbonyl chlo-
ride) Nα-protected onto the Nα-unprotected amino group of the growing
peptide chain anchored to the resin [Cha04]. To allows a side-specific attach-
ment of a fluorescent marker and therefore observing the dendrimer cellular
distribution via confocal microscopy this dendrimer was equipped with a
p-nitro-2-pyridinesulphenyl (Nyps) group.
Figure 2.2: Structure of the 8+ Arginine peptide dendrimer Np4.
2.2 Labelling of the Np4 Peptide Dendrimer with
Fluorescent Dyes
For effective tracing of the pathway through the cell membrane and quanti-
tative evaluation of cellular uptake the Np4 peptide dendrimer was labelled
with Atto550 fluorescent dye by using the p-nitro-2-pyridinesulphenyl (Npys)
group which make this labelling very specific.
The labelling of the Np4 peptide dendrimer was performed in two steps.
In the first step of the labelling reaction the fluorescent dye Atto550 as a N-
Hydroxysuccinimide (NHS) esters was attached to the amino function of
the cystein via a nucleophilic substitution. The primary amino group of the
cystein is especially nucleophilic and therefore suitable for conjugation with
several reactive groups such as isocyanates, acyl azides, NHS esters, sulfonyl
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chlorides and many others. The NHS-ester of the fluorescent dye react with
the primary amine in physiologic to slightly alkaline conditions to yield stable
amide bonds. The reaction was carried out in carbonate buffer (pH 9.0) at 30 ◦C
and releases N-Hydroxysuccinimide (Figure 2.3 step I). In the second step
TCEP (tris(2-carboxyethyl)phosphine) was applied for the selectively reducing
of the disulfide bound in the Np4 dendrimer and subsequent coupling with
the cystein-Atto550 compound (Figure 2.3 step II).
After the labelling reaction was completed the fluorescent labelled pep-
tide dendrimer (Np4Atto550) was purified by using a Slide-A-Lyzer Dialysis
Cassettes to remove the free dye and non-reacted compounds (procedure see
chapter 3.
2.3 Complexation studies
In the proceeding chapter the mechanism of dendriplex formation between a
novel class of low generation peptide dendrimers and DNA at various sizes is
examined. There aremany different techniques for characterizing dendriplexes,
which can be divided into twomain groups: (i) direct methods such as electron
microscopy, atomic force microscopy, radio immunoassay, gel electrophoresis
and (ii) indirect methods such as measurement of absorbance, dynamic light
scattering, calorimetry and others [SPB09]. With direct techniques we can
directly observe dendriplexes and distinguish them from pure dendrimers
and nucleic acid. In contrast with indirect techniques, the parameters of a
solution containing all the components are measured and analyzed in terms
of the difference between the parameters of a complex and those of the pure
dendrimer, respectively amino acid. In this work I used gel electrophoresis as
a direct technique and a PicoGreen assay as an indirect method to study the
peptide dendriplex formation and stoichiometry.
2.3.1 Electrophoretic Mobility Shift Assays (EMSA) for Study the
Complex Formation between Np4 Peptide Dendrimer and
DNA Various Sizes
An interesting and very important aspect concerning the application of the
peptide dendrimers as a synthetic gene delivery vector is the characterization
of the dendrimer/DNAcomplex (dendriplex). The complex formation between
peptide dendrimers and nucleic acidswith different size and at different charge
ratios in this work was determined by the gel electrophoresis mobility shift
assay (EMSA) [LPC92]. This method is widely-used rapid and sensitive and
allows detection of protein and nucleic acid interactions [OA87; And93]. It is
based on the fact that the electrophoretic mobility of a nucleic acid complex is
typically less than that of a free nucleic acid [HF07].
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Figure 2.3: Specific labelling of the Np4 peptide dendrimer. In the step I cou-
pling of the cysteine with Atto550 NHS-ester. Step II: Coupling of the fluores-
cent labelled cysteine with the Np4 peptide dendrimer.
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Agarose Gel Electrophoresis Retardation Assay for Dendriplex Formation
Studies
Complex formation between plasmid DNA (pDNA) and positively charged
peptide dendrimers will neutralize the net negative charge of the DNA and as
a consequence will inhibit the migration during agarose gel electrophoresis
assay. This assay was initially performed in order to obtain more informa-
tion about the structure and mechanism of dendriplex formation. Complex
formation of plasmid DNA (pmax GFP 4.7 kbp) and four unlabelled asym-
metric peptide dendrimers of different charges (4 respectively 8 surface amine
) Np3, Np4, Np5, Np6 (structures see also Figure 3.1 and Figure 3.2) at four
different N/P charge ratios (the ratios of moles of the amine groups(N) of
cationic polymers to those of the phosphate(P) ones of DNA) was examined
by the electrophoretic mobility of the complex on one percent agarose gel (for
preparation see section 3.2.2).
The dendriplexes were prepared by gently mixing of 1µg pDNA with
the required amount of dendrimer (4+Np3, 8+Np4, 4+Np5 and 8+Np6) and
incubate for at least 30min at room temperature (see subsection 3.3.5). Gel
electrophoresis sample buffer was added to each sample and loaded on a 1%
agarose gel containing 1µgml−1 ethidium bromide. Then the electrophore-
sis was performed in 1XTAE buffer for 180min at 80W constant power. The
imaging was conducted by illuminating with UV illuminator.
The unlabelled Np4 peptide dendrimer shows completely retardation the
migration of the pDNA even at lower charge ratios (N/P ratio of 1) (Figure 2.4).
These results suggest that a effective dendriplex formation between this
dendrimer and the pDNA occurs already at low charge ratios and the consti-
tuted complexes are physically stable. Due to their ability to efficiently complex
pDNA the Np4 peptide dendrimer will be used for future investigations of the
dendriplexes uptake and internalization mechanism in living cells (section 2.4).
By performing the agarose gel electrophoresis assay with the unlabelled
Np3, Np5 and Np6 peptide dendrimers the lower 4+ generation dendrimers
(Np3 and Np5) appeared not to effective inhibit the DNA migration. Only a
low retardation of the DNAmigration was observed by using the Np3 peptide
dendrimer at a charge ratio of 5 and 10. The Np5 dendrimer does not show
any inhibition of the DNA migration for all the applied charge ratios. On the
other hand the higher generation 8+ peptide dendrimer Np6 complex plasmid
DNA albeit at a N/P ratio of five (Figure 2.5).
These results confirm that the dendrimer/DNA complex formation is of
electrostatic nature and strongly depends on the N/P ratio as well as on the
number of dendrimer head group charges.
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Figure 2.4: Agarose gel retardation assay of Np4-pmaxGFP peptide den-
driplexes at four different charge ratios (1, 2, 5 and 10 respectively). Plasmid
DNA concentration (1µg).
Polyacrylamide Gel Electrophoresis Assay for Dendriplex Formation
Studies
While the agarose gel electrophoresis is mainly used for separating larger
macromolecules such a nucleic acids, the polyacrilamide gel electrophoresis is
widely employed to analyse the size, amount and purity of polypeptides and
proteins [Ham98]. In order to enhance the sensitivity of dendriplex detection
especially if smaller oligonucleotide are used, I applied polyacrilamide gel elec-
trophoresis assay (PAGE). In this studies I investigated the dendriplex forma-
tion between fluorescent labelled Np4Atto550 peptide dendrimer and dsDNA-
Atto655 in order to apply this system for tracing of the pathway through the
plasma membrane and quantitative evaluation of the cellular uptake by laser
scanning microscopy (see section 2.4).
Polyacrilamide forms gels with pores of a much more controlled and uni-
form size than agarose does. Therefore fragments as small as 10 base pairs
and up to 1 kbp can be separated with a resolution of as little as 1 bp [GR81;
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Figure 2.5: Agarose gel retardation assay of Np3-, Np5- and Np6-pmaxGFP
peptide dendriplexes at four different charge ratios. First line 1kb DNA ladder
and last line plasmid DNA (pmaxGFP). The N/P ratios are equal for all the
peptide dendrimers tested 1, 2, 5 and 10 respectively.
LPC92]. In general, peptide dendrimer-nucleic acid complexes will migrate
more slowly across the polyacrilamide matrix than the corresponding free
DNA.
The dendriplex formation between fluorescent labelled Np4Atto550 den-
drimer and 83 base pairs double stranded DNA labelled with Atto655 was
performed for eight different N/P ratios (0.6, 1, 2, 3, 5, 7, 10 and 20 respectively)
as described in subsection 3.3.5. Free DNA and dendrimer/DNA complexes
(dendriplexes) were separated on a native 0.75mm thick 12% polyacrilamide
gel without sodium dodecyl sulphate (SDS) as described in subsection 3.2.2.
The gel was scanned on a gel scanner with wavelengths suitable for excitation
of Atto655.
As seen on Figure 2.6 there are two types of bands. The free DNA have
a high mobility and runs faster, whereas the mobility of the dendriplexes is
retarded. A partial complexation between the labelled Np4 peptide dendrimer
and the DNA was observed by all the charge ratios mentioned above. On the
other hand by applying higher charge ratios of 50 and higher I observed a full
DNA retardation (see also Appendix A).
These results confirm that the DNA binding ability of the fluorescent
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Figure 2.6: PAGE images showing the partial complexation between fluorescent
labelled Np4Atto550 peptide dendrimer and a fluorescent labelled 83 base
pairs double stranded oligonucleotide (HXXLAtto655) at eight different charge
ratios. Line one DNA only. Lines 2 to 9 N/P ratios 0.6, 1, 2, 3, 5, 7, 10 and 20
respectively.
labelled Np4Atto550 peptide dendrimer is charge ratio dependant. Due to
some disadvantages of the EMSA assay such as the limitation that the samples
are not at chemical equilibrium during electrophoresis I could not observed
complete dendrimer/DNA complex formation at a charge ratios up to 20. Full
DNA complexation was observed at a N/P ratio of 50.
2.3.2 PicoGreen Assay for Peptide Dendriplex Characterization
As already confirmed in subsection 2.3.1 the basis of the interaction between
DNA and peptide dendrimers is of an electrostatical nature and results in a
physically stable complex. For more comprehensive characterization of the
peptide dendriplex I performed a PicoGreen intercalation assay. This method
was found to be highly sensitive for monitoring complex formation [Cho+04].
PicoGreen reagent is a very sensitive probe for detection and quantification of
a small amount of double-stranded DNA (dsDNA) in solution. If PicoGreen
binds to dsDNA a highly luminescent complex is formed when compared to
the free dye in solution [Sin+97; Dra+10].
In this assay I used both unlabelled and fluorescent labelled Np4 peptide
dendrimers and tested double stranded oligonucleotides at four different
length (20, 38, 62, 83 base pairs) as well as a plasmid DNA (pmaxGFP 4.7 kbp)
at seven different N/P ratios (0.6, 1, 2, 3, 5, 10 and 20).
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Figure 2.7: PicoGreen fluorescence decreasing by complex formation between
fluorescent labelled Np4Atto550 peptide dendrimer and: (a) double stranded
20 base pairs oligonucleotide labelled with Atto655 (HOAtto655) (b) a 4.7 kbp
plasmid DNA (pmaxGFP).
2.3. COMPLEXATION STUDIES 45
Prior to all studies, dendriplexes were prepared by mixing 1µg of DNA
with the appropriate amount of Np4 peptide dendrimer in double distilled
sterile water and incubated for 30min at room temperature. A fresh prepared
aqueous solution of the PicoGreen reagent was then added and incubated
for another 5min at room temperature protected from light. The samples
fluorescence was measured using a Varian fluorescence spectrophotometer
(ex.488 nm, em. 520 nm).
The non-complexed amount of the DNA is then exposed to the PicoGreen
reagent, and the resultant fluorescence decreases according to the degree of
dendriplex formation. As a result the observed fluorescence decrease of the
PicoGreen reagent is proportional to the complexation between DNA and the
cationic peptide dendrimer Np4 (fluorescent labelled as well as unlabelled).
Plasmid DNA and double stranded oligonucleotide at different length formed
dendriplexeswith theNp4 peptide dendrimers. The continuous decrease of the
PicoGreen reagent fluorescence with increasing the charge ratio corresponds
to higher DNA amount bound in dendriplexes (see also Figure 2.7).
I observed similar pattern of PicoGreen fluorescence decreasing by apply-
ing labelled and unlabelled dendrimer. Both fluorescent labelled and unla-
belled Np4 peptide dendrimer are able to form complexes with larger pDNA
as well as with short oligonucleotides. More data of the PicoGreen assays can
be find in Appendix A.
(a) (b)
Figure 2.8: Relative fluorescence decreasing of PicoGreen by dendriplex forma-
tion between: (a) unlabelled Np4 peptide dendrimer and DNA different sizes,
(b) fluorescent labelled Np4Atto550 peptide dendrimer and DNA different
sizes. Results are represented as mean ±SD.
As presented in (Figure 2.8, the inhibition of the PicoGreen fluorescence
resulting from pre-complexation with the dendrimer increased with increas-
ing charge ratio and depends on the DNA size. The largest plasmid DNA,
appears to have the strongest complexation ability to the labelled as well to
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Figure 2.9: (a) Standard curve of PicoGreen fluorescence versus DNA concen-
tration for 83 base pairs double stranded DNA oligonucleotide labelled with
Atto655 fluorescent dye, (b) Percentage of DNA bound in peptide Np4Atto550-
HXXLAtto655 dendriplexes at different charge ratios. Results are represented
as mean ±SD.
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the unlabelled Np4 dendrimer. Already at a charge ratio of two the relative
fluorescence decreases up to 80%. On the other hand shorter double stranded
20 bp DNA cause a relative fluorescence decrease of approximately up to 25%
at the same charge ratio conditions. The relative fluorescence decrease reach a
plateau near zero at around a charge ratio of fivewhich indicates approximately
full DNA complexation for the entire DNA sizes both for labelled as well as
unlabelled Np4 peptide dendrimers. Dendrimers bind to DNA sufficiently
strongly that they cannot be displaced by PicoGreen.
The amount of DNA bound in dendriplexes were determined by the DNA
standard curve (Figure 2.9 (a)). At a charge ratio of three almost 90% of the
DNA is bound in dendriplexes (Figure 2.9 (b)). Near to full DNA complexation
was observed at a charge ratio of 10 for the unlabelled as well for the labelled
Np4 peptide dendrimer.
2.4 Peptide Dendrimers as DNA Delivery Vectors
This chapter refers to the implementation of the peptide dendriplexes as trans-
fection reagents for DNA delivery into living cells. To allow the observation of
the dendriplexes distribution in a cell by laser scanning microscopy the Np4
peptide dendrimer was labelled with Atto550 and ssDNA as well as dsDNA
at different sizes labelled with Atto655 fluorescent dye were applied.
The transfection efficiency of the peptide dendrimers, cellular entry mech-
anism and uptake are investigated by examining the effects of the charge ratio,
the size of the DNA as well as the impact of different endocytosis inhibitors
on the dendriplex cell entry.
In order to determine if the nature of the cell line affects the transfection ef-
ficiency of the peptide dendrimers I test two different cell lines; NIH3T3 EpoR
(mouse embryonic fibroblast cells expressing Erythropoietin (Epo) receptor)
and HeLa (human epithelial cervical carcinoma cells). In addition the intracel-
lular trafficking of the dendriplexes to the lysosomes and the mitochondria is
presented by the application of different markers.
2.4.1 Cytotoxicity of Peptide Dendrimers
Amajor concern when introducing peptide dendrimers for DNA delivery into
living cells is directed towards the biocompatibility of these particles. In order
to be usable in gene delivery applications, dendrimers have to be non-toxic
and non-immunogenic [Kha+09].
One of the first steps for the biocompatibility test is the performance of
in vitro toxicity screens for different cell lines. In general, cationic dendrimers
show increasing toxicity with increases in concentration and generation [Izz05].
A low-generation of asymmetric dendrimers is known to exhibit minimal cell
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toxicity and efficiently complexes with DNA [SSP11]. The toxicity of the used
fluorescent labelled Np4 peptide dendrimer is investigated by the Trypan Blue
exclusion assay (subsection 3.3.8) in two different cell lines (NIH3T3 EpoR
and HeLa). This cell viability assay is based on the principle that living cells
posse an intact cell membrane that excludes certain dyes such as Trypan Blue,
whereas dead cells do not.
(a) (b)
Figure 2.10: Fluorescent labelled peptide dendriplexes exhibit low toxicity to
NIH3T3 EpoR (blue colour) and HeLa (red colour) cells (a) Cytotoxicity of
fluorescent labelled Np4Atto550-OAtto655 dendriplexes. (b) Cytotoxicity of
fluorescent labelled Np4Atto550-pmaxGFP peptide dendriplexes. Controls
are untreated cells (control) and cells incubated with 20 base ssDNA labelled
with Atto655 (OAtto655) and pmaxGFP respectively. Results are represented
as mean ±SD.
For dendriplex cytotoxicity evaluation, the DNA concentration was kept
constant at 200 nm. This value was selected during preliminary experiments
as it provided the highest levels of transfection allowed for cell viability.
For the Trypan blue exclusion assay cells were grown in culture medium
as described in (subsection 3.2.1) and seeded on six-well plates in a density
of 4.104 cells/ml. Dendriplexes were prepared in double distilled water as
described in (subsection 3.3.5) for six different N/P (the ratios of moles of the
amine groups(N) of cationic polymers to those of the phosphate(P) ones of
DNA) ratios (0.6, 1, 5, 10, 50 and 100 respectively) and added to the cells. At the
time of transfection, the medium was replaced by serum reduced OPTIMEM
transfection media. The dendriplexes were incubated with the cells for 4 h
at 37 ◦C and then removed. The cells were then trypsinized and mixed with
the Trypan Blue solution for about 5min. The percentage of viable cells was
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calculated as following:
viable cells(%) = total number of viable cells per ml of aliquot
total number of cells per ml of aliquot
x 100
(2.1)
The used fluorescent labelled Np4Atto550 peptide dendrimer show low cy-
totoxicity at charge ratios ranging from 0 to 100 (Figure 2.10). This interval
includes the N/P ratios applied in future transfection experiments. Toxic-
ity was observed to increase with increasing positive charge density by ap-
plying 62 (HXLAtto655) and 83 (HXXLAtto655) base pair double stranded
oligonucleotides. I observed almost 35% cell mortality for the Np4Atto550-
HXLAtto655 peptide dendriplexes, whereas the Np4Atto550-HXXLAtto655
caused 45% cell death (Appendix A). These observations claim the hypothesis
of a presence of high concentration of cationic amines which damages the cell
membranes.
2.4.2 NIH3T3 EpoR Cell Line
The NIH3T3 EpoR cells are mouse embryonic fibroblast cells expressing Ery-
thropoietin (Epo) receptor. This cell line was established in our group for
dynamic studies on the Jak/STAT-pathway. I choose this cell line as a mam-
malian cell line to explore the transfection efficiency of the fluorescent labelled
Np4Atto550 peptide dendrimer.
Charge Ratio Dependency of the Dendriplex Transfection Efficiency by
NIH3T3 EpoR cells
As shown in the previous experiments the fluorescent labelled peptide Np4
dendrimer is able to form complexes with ssDNA as well as with dsDNA
different sizes at various N/P charge ratios (see section 2.3). In order to es-
tablish an optimal protocol for the use of this dendrimer as a DNA transport
vehicle into living cells it is imperative to evaluate the transfection efficiency
of dendriplexes with varying N/P ratios. This dendriplexes have to provide a
maximal transfection efficiency atminimal cell toxicity. Therefore I investigated
the transfection ability of the fluorescent labelled dendriplexes at five different
charge ratios by maximal cell viability (see also Appendix A).
The first question to be answeredwas to determine an optimal charge ratios
for delivery of DNA into living NIH3T3 EpoR cells via fluorescent labelled
Np4Atto550 peptide dendrimer. Due to the necessity keeping the total charge
density of the dendriplexes and the related cell toxicity as low as possible
I chose 20 base (the larger the DNA, the more negative charges are present
and therefore higher positive charge density is needed) ssDNA labelled with
Atto655 fluorescent dye (OAtto655). The Np4Atto550 peptide dendrimer is
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Figure 2.11: Charge ratio dependency of the transfection efficiency of fluores-
cent labelled Np4 by NIH3T3 EpoR cells. (a) The transfection efficiency of the
Np4Atto550 peptide dendrimer by NIH3T3 EpoR cells strongly depends on
the charge ratio. A 20 base ssDNA labelled with Atto655 in a concentration
of 200 nmwas used. Images are represented as an overlay between the green
channel Np4Atto550 signal and the red channel OAtto655 signal. N/P ratios
0.6, 1, 2, 5 and 10 respectively images A to E. The scale bar corresponds to
15µm. (b) The total DNA cell fluorescence by NIH3T3 EpoR cells shows a
significant increase with the N/P ratio. The results are represented as mean
from three independent experiments ±SD.
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eight times positively charged. The ssDNA have 20 base which results in a
total of 20 negative charges.
Due to the negatively charged plasma membrane [Alb02; Yeu+08] the net
positive charge of the dendriplex is essential for the cell entry as facilitating the
binding to the membrane and the cellular uptake via endocytosis [Dua+09].
With increasing positive charge density the cytotoxicity rises. Therefore the de-
termination of an charge ratiowhichwill enable dendriplex in vivo applications
is of great significance.
In order to determine the conditions for using the fluorescent labelled
8+ Np4 peptide dendrimer as a transfection reagent I tested five different
N/P ratios particularly 0.6, 1, 2, 5 and 10. Prior to all studies, the Np4Atto550
peptide dendrimer wasmixedwith 20 base ssDNA labelled with Atto655 at the
defined N/P ratios in double distilled sterile water and incubated for 30min at
room temperature to allow complex formation (see subsection 3.3.5). The DNA
concentration was kept constant at 200 nm. NIH3T3 EpoR cells were cultured
as described in (subsection 3.2.1) and seeded on a IBIDI µ-Slide with 8 wells
with a density of 2.104 cells/well and maintained for 48 h at 37 ◦C to reach a
confluence of approximately 80%.
For determination of the optimal transfection ratio cells were treated with
dendriplexes at various N/P ratios (0,6; 1; 2; 5 and 10). Prior to transfection the
normal grow medium was replaced by OPTIMEM serum reduced medium.
The dendriplexes were added to the cells and incubated for 4 h at 37 ◦C. Once
the transfection was completed the transfectionmixture was then removed and
the cells were washed twice with PBS. The cellular uptake was determined via
confocal laser scanning microscopy and quantified using the public domain
ImageJ software.
The NIH3T3 EpoR cells show a different fluorescent signal depending
on the N/P ratio. By applying N/P ratios of 0.6 and 1 there are no DNA
fluorescence in the cells. A weak DNA fluorescence signal in the cell was
observed at a charge ratio of two. At a N/P ratio of 5 and especially 10 a
significant increase of the DNA cell fluorescence was determined (Figure 2.11
(a)). The distribution of the DNA in the cell does not appears equally but
rather as a small spots in the cytoplasm. The DNA signal was limited to the
cell cytoplasm. A nuclear DNAfluorescencewas not observed (see AppendixA
for more details).
The transfection efficiency of the fluorescent labelled Np4 peptide den-
driplexes strongly depends on the charge ratio. As shown in Figure 2.11 (b) at
a charge ratio of 0.6 no DNA fluorescence in the cells could be observed. With
increasing the N/P ratio the dendriplexes became more positively charged
and the cell entry is facilitated. I detected a noticeable increase of the OAtto655
total cell fluorescence at a charge ratio of two.
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Maximal transfection efficiency using the labelled Np4Atto550 peptide
dendrimer by moderate cytotoxicity was determined at N/P ratio of 10. Al-
though a charge ratio of 5 was suitable as well ant as a compromise in order
to keep the cell toxicity as low as possible this charge ratio will be applied in
future experiments.
In order to determine if the fluorescent labelling influences the dendrimer
transfection ability I performed the transfection experiment described above
also with the unlabelled Np4 peptide dendrimer.
The unlabelledNp4peptide dendrimer shows significantly low transfection
efficiency compared to the fluorescent labelled one. I observed a weak DNA
fluorescence signal with a spot-like distribution in the cells by applying a
charge ratios of 5. N/P ratios of 20 and 50 induced a non-specific attachment
of the unlabelled Np4 peptide dendriplexes to the cell culture-dish surface
which appears as a random distributed fluorescent spots (see Figure 2.12).
Due to the higher background signal caused from the unspecific dendriplexes
surface binding the quantitative analyse of the DNA cell fluorescence was not
possible.
The transfection efficiency of the unlabelled Np4 peptide dendrimer by
NIH3T3 EpoR cells is significantly low and even depends on the charge ratio.
Compared to the fluorescent labelled Np4Atto550 peptide dendriplexes the
intracellular distribution of the unlabelled dendriplexes show very random
and unspecific distribution. Du to this disadvantages the unlabelled Np4
peptide dendrimer will not be used in future experiments.
Applying lower N/P ratios (0.6 and 1) between DNA and fluorescent
labelled as well as unlabelled Np4 peptide dendrimer leads to formation
of a negatively charged or neutral dendriplexes. Having in mind that the
plasma membrane is negatively charged the interaction with this dendriplexes
will become difficult or impossible. Therefore I didn’t observe DNA delivery
into the cells by lower charge ratios with both labelled and unlabelled Np4
peptide dendrimers which can be logically linked to the absence of dendriplex
interaction with the cell membrane.
Highly positively charged dendriplexes promote the binding to the nega-
tively charged plasma membrane and therefore facilitate the cellular uptake.
Intracellular DNA delivery by NIH3T3 EpoR cells using labelled Np4Atto550
peptide dendrimer was observed at a N/P ratio of 2. In contrast the unlabelled
Np4 peptide dendrimer was able to deliver DNA into the cells at a charge
ratio of five. A general problem by increasing the positive charges of the den-
driplexes is the enhanced cytotoxicity. The distribution of fluorescent labelled
as well as unlabelled dendriplexes occur in near 100% the cells and is limited
to the cell cytoplasm. No nuclear distribution was observed for both labelled
and unlabelled Np4 peptide dendriplexes.
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Figure 2.12: Charge ratio dependency of the transfection efficiency of the un-
labelled Np4 peptide dendrimer by NIH3T3 EpoR cells. A 20 base ssDNA
labelled with Atto655 (OAtto655) in a concentration of 200 nm was used. Incu-
bation time 4 h at 37 ◦C. N/P ratios 0.6, 5, 10, 20 and 50 respectively images A
to E. The scale bar corresponds to 15µm.
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Size Dependency of the Transfection Efficiency by NIH3T3 EpoR Cells
Another interesting and important question is the size limitation of the DNA
which peptide dendrimers can transport across the plasma membrane. For
this purpose I applied fluorescent labelled Np4Atto550 peptide dendrimer to
study the effect of the DNA length on the transfection efficiency.
For this experimentNIH3T3 EpoR cells were seeded on IBIDI µ-Slidewith 8
wells in a density of 2.104 cells/well. Dendriplexes were prepared as described
in subsection 3.3.5 using ssDNA as well as dsDNA different sizes (20, 38, 62,
83 base subsection 3.1.2) at a concentration of 200 nm. The transfection occurs
in serum reduced OPTIMEM transfection medium at an incubation time of
4 h at 37 ◦C. The transfection efficiency was determined by laser scanning
microscopy and quantified using the ImageJ software.
I observed a significant DNA fluorescent signal into the cell by all the
applied ssDNA sizes (Figure 2.13). The fluorescence distribution was limited
to the cell cytoplasm and occurs not equally. The fluorescent labelled peptide
Np4Atto550 dendrimer is also able to complex and transport ssDNA with
a size up to 83 base in to living mouse fibroblast. Double stranded DNA
can be transported across the cell membrane with a limitation of 40 base
pairs (Figure 2.14 (a)). The limitation is based on the higher positive charge
density by applying larger DNA and their associated high cytotoxicity (see
also Appendix A). This may results in a bottleneck regarding the application
of the fluorescent labelled Np4 peptide dendrimer as a transport vehicle for
DNA into living cells.
Although larger DNA shows high ability to complex formationwith the flu-
orescent labelled and unlabelled Np4 peptide dendrimer (see subsection 2.3.2)
their transfection efficiency in NIH3T3 EpoR cells is lower than for smaller
DNA fragments. The total cell fluorescence decreases with DNA size increase
(Figure 2.14 (b)).
2.4.3 HeLa Cell Line
Does the nature of the cell line affect the transfection efficiency of the den-
driplexes? Seeking to answer this question I chose the HeLa cell line as a
human cancer cell line to examine the transfection efficiency of the peptide
dendriplexes .
Charge Ratio Dependency of the Dendriplex Transfection Efficiency by
HeLa Cells
The influence of the cell line nature on the dendriplexes transfection efficiency
was investigated by transfection experiments using the fluorescent labelled
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Figure 2.13: Dependency of the transfection efficiency of the fluorescent la-
belled Np4Atto550 peptide dendriplexes on the ssDNA size by NIH3T3 EpoR
cells. All the experiments were performed with a N/P ratio of five a ssDNA
concentration of 200 nm and an incubation time of 4 h. Images A to D are
overlays between the green channel Np4Atto550 signal and the red channel
DNA-Atto655 signal and represent the transfection with 20, 38, 62 and 83 base
ssDNA. The scale bar corresponds to 15µm.
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Figure 2.14: (a) Dependency of the transfection efficiency of the labelled
Np4Atto550 peptide dendrimer on the dsDNA size by NIH3T3 EpoR cells. All
the experiments were performed with a N/P ratio of five by using a 20 and 40
base pairs dsDNA at a concentration of 200 nm. The scale bar corresponds to
15µm. (b) Size dependency of the total DNA cell fluorescence byNIH3T3 EpoR
cells transfected with fluorescent labelled Np4Atto550 peptide dendrimer and
ssDNA as well as dsDNA different sizes. The results are represented as mean
value from three independent experiments ±SD.
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Np4Atto550 peptide dendrimer in HeLa cells by the same conditions as with
the NIH3T3 EpoR cell line.
For this experiment HeLa cells were cultured as described in (subsec-
tion 3.2.1). Cells were seeded on IBIDI µ-Slide with 8 wells in a density of
2.104 cells/well. The dendriplex formation occurs in double distilled sterile
water like described in (subsection 3.3.5). Similar to the NIH3T3 EpoR cell
lines I also used 20 base ssDNA labelled wit Atto655 and fluorescent labelled
Np4Atto550 peptide dendrimer at five different charge ratios (0.6, 1, 2, 5 and
10 respectively). The charge ratio dependency of the transfection efficiency of
the labelled Np4Atto550 peptide dendrimer was then determined via confocal
laser scanning microscopy. The quantification of the total DNA cell fluores-
cence was calculated by using the public domain ImageJ software.
Identically to the NIH3T3 EpoR cell line HeLa cells show enhanced trans-
fection efficiency with increase of the charge ratio. I observed a weak non
equally distributed DNA fluorescence signal into the cells already at a N/P
ratio of 0.6 (Figure 2.15). At a N/P ratio of 1, 2, 5 and especially 10 a significant
increase of the DNA cell fluorescence was determined (see also Appendix A).
The DNA fluorescence distribution by HeLa cells was as well limited into the
cell cytoplasm. Nuclear DNA fluorescence signal was not observed. Due to
the higher transfection efficiency of this cell line compared to NIH3T3 EpoR
cell line the incubation time for the HeLa cells was then shortened to 3 h.
Size Dependency of the Transfection Efficiency by HeLa Cells
AlthoughHeLa cells are much easier to transfect the ability of the dendriplexes
to transport DNAof various lengths across the plasmamembrane is still limited
[EBD05].
Using the same condition as for the NIH3T3 EpoR cells I tested the trans-
fection efficiency of the fluorescent labelled Np4Atto550 peptide dendrimer
to transport ssDNA and dsDNA different length into living HeLa cells. The
transfection experiment was performed at a N/P ratio of five as described
above and occurs in serum reduced OPTIMEM transfection medium. Fluores-
cent labelled ssDNA as well as dsDNA different sizes (20, 38, 62, 83 base was
allied. The incubation time was 3 h at 37 ◦C. The transfection efficiency was
determined by laser scanning microscopy and quantified using the ImageJ
software.
Similar to the NIH3T3 EpoR cells line I determine DNA fluorescence signal
into the cells by all the ssDNA sizes (Figure A.15). Double stranded DNA can
be transported across the cell membrane with a limitation of 40 base pairs
(Figure 2.17). The fluorescence distribution for both ssDNA and dsDNA occurs
not equally and was limited to the cell cytoplasm.
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Figure 2.15: (a) Charge ratio dependency of the transfection efficiency by HeLa
cells using Np4Atto550 peptide dendrimer and 20 base ssDNA labelled with
Atto655 (OAtto655) in a concentration of 200 nm. Images are represented as
overlay from green channel Np4Atto550 signal and red channel OAttO655
signal. The colocalization between the green and the red channel appears
yellow. N/P ratios 0.6, 1, 2, 5 and 10 in the images A to E. The scale bar
corresponds to 15µm. (b) Charge ratio dependency of the DNA total cell DNA
fluorescence by HeLa cells transfected with Np4Atto550-OAtto655 peptide
dendriplexes at different N/P ratios. Results are reported as mean value ±SD
(n = 3).
2.4. PEPTIDE DENDRIMERS AS DNA DELIVERY VECTORS 59
Figure 2.16: Dependency of the transfection efficiency of labelled Np4Atto550
peptide dendrimer on the ssDNA size byHeLa cells. The transfection efficiency
of the Np4Atto550 peptide dendrimer by HeLa cells is even dependant on the
ssDNA size. Images A toD are overlays between the green channel Np4Atto550
signal and the red channel DNA-Atto655 signal and represent the transfection
with 20, 38, 62 and 83 base ssDNA. Incubation time 3 h and DNA concentration
200 nm. The scale bar corresponds to 15µm.
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Figure 2.17: (a) DNA size dependency of the transfection efficiency of fluo-
rescent labelled Np4Atto550 peptide dendriplex by HeLa cells. Images are
represented as overlays between the green channel Np4Atto550 and the red
channel DNA-Atto655. A) 20 base pair dsDNA, B) 40 base pair dsDNA. Incu-
bation time 3 h and a DNA concentration of 200 nmwas applied. The scale bar
corresponds to 15µm. (b) Size dependency of the total DNA cell fluorescence
by HeLa cells transfected with fluorescent Np4Atto550 peptide dendrimer and
dsDNA different sizes. The results are represented as mean values from three
independent experiments ±SD.
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Taking advantage of the easier transfection ability ofHeLa cells, this cell line
was used to investigate the possibility of the fluorescent labelled Np4Atto550
peptide dendrimer to transport plasmid DNA into living cells. Transporting
larger DNA across the plasma membrane is a very important tool for estab-
lishing the peptide dendrimers as a gene delivery vector. In the light of all
the complexation studies performed with the unlabelled as well as with the
fluorescent labelled Np4 peptide dendrimer it becomes obvious that this den-
drimer can efficiently complex pDNA (pmaxGFP) with a size of 4.7 kbp (see
subsection 2.3.1). Similar to the complexation experiments I used the pmaxGFP
plasmid in a N/P ratio of 5 to study the ability of the Np4 peptide dendrimer
to successfully transport plasmid DNA across the plasma membrane.
The transfection experimentswere performed in serum reducedOPTIMEM
transfection media at four different charge ratios (1, 2, 5 and 10). Incubation
time of 4 h and a pmaxGFP concentration of 1µm was applied. Gene delivery
achieved by the unlabelled Np4 peptide dendrimer was studied 36 h post-
transfection, by visualization of the Green Fluorescent Protein (GFP) expres-
sion using fluorescence microscopy. Considering the fact that the dendriplex
distribution of smaller fluorescent labelled oligonucleotides occurs only in the
cytoplasm but not in to the nucleus (Figure A.16 (a)) a nuclear Green Fluo-
rescent Protein expression is not to be expected. I observed low cytoplasmic
GFP expression by a N/P ratio of two and higher 36 h after transfection (Fig-
ure 2.18). The reason for the cytoplasmic GFP expression could be explained by
a very little nuclear delivery of the Np4-pmaxGFP peptide dendriplexes which
could not be observed at the confocal pictures or with a possible mitochondrial
protein expression [Mar+06].
The fluorescent labelled peptide Np4 dendrimer shows relatively low cell
toxicity (Appendix A) and is also suitable as DNA transport vehicle for in vivo
applications. The transfection efficiency is strongly dependent on the charge
ratio and the DNA size. Higher charge ratios deliver higher positively-charged
dendriplexes and facilitate their binding to the cell membrane. Therefore the
cellular uptake becomes easier and I observed a transfer of more DNA into
the cells (see also Figure 2.19(a)). Less DNA were transferred into the cells
with increasing the length of the DNA and applying double stranded DNA,
which leads to the conclusion that smaller single stranded DNA is more easily
taken up by the cells as larger double stranded DNA. The cell nature plays as
well an important role: HeLa cells are much easier to transfect compared to
NIH3T3 EpoR cells. Comparing the total cell fluorescence of both cell lines
it should be noted that the HeLa cells show a higher DNA fluorescence than
NIH3T3 EpoR cells (see also Figure 2.19 (b)). In all the experiments performed
below the intracellular distribution of the fluorescent peptide dendriplexes
was limited only to the cytoplasm. A nuclear distribution was not observed by
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Figure 2.18: Fluorescence microscopy images showing Green Fluorescent Pro-
tein (GFP) expression in living HeLa cells 36 h post-transfection using Np4
peptide dendrimer as a transfection reagent. N/P ratios 1, 2, 5 and 10 in the
images A to D, negative control (only pmaxGFP) image E and positive control
by applying Lipofectamine as a transfection reagent image F. Incubation time
4 h, DNA concentration 1µm. Imaging 36 h after transfection. The scale bar
corresponds to 15µm.
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Figure 2.19: Comparison of the transfection efficiency of fluorescent labelled
Np4Atto550 peptide dendrimer by NIH3T3 EpoR and HeLa cells in terms of
(a )charge ratio and (b) ssDNA respectively dsDNA size. HeLa cells red colour,
NIH3T3 EpoR cell line blue colour. The results are represented as mean values
from three independent experiments ±SD.
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both cell lines.
2.4.4 Uptake and Intracellular Traffic of Peptide Dendriplexes in
Human Cervix Carcinoma Cells
A key aspect in developing more efficient vectors for DNA delivery is the
fundamental understanding of the cellular uptake and intracellular processing
of their gene delivery systems. Dendrimers play an important role in the non
viral gene therapy, but also for research in cell and system biology [Dyk01;
Pad+09]. Despite their wide use as a non viral vector very little is known
about the mechanism of cellular uptake, subsequent release and distribution
[Ger+06]. The majority of reports about cell entry mechanism of dendriplexes
suggest that endocytosis is the most preferred route [CS03; Qi+10]. For deeper
understanding of the cellular uptake and internalization of the peptide den-
drimer/DNA complexes I determined the effect of a set of chemical inhibitors
of endocytosis that inhibit specific route of uptake. In addition, the intracellu-
lar trafficking of the dendriplexes was investigated by colocalization studies
with Mito- and Lysotracker respectively used as markers for mitochondria
respectively lysosomes staining.
Dendriplex Uptake Studies
As already mentioned above the main cell entry mechanism of dendriplexes
is represented by endocytosis. This is the process in which eucaryotic cells
form and internalize plasma membrane vesicles. Endocytosis involves the cel-
lular internalization and sorting of extracellular molecules, plasma membrane
proteins and lipids. This process plays an important role for the transport
of macromolecules into eucaryotic cells. Additionally cells use this process
to maintain homeostasis, to obtain food and to defend themselves [Alb02].
Endocytotic processes can be classified in two broad categories which differ
according to the size of the formed endocytotic vesicles: phagocytosis (cell
eating) and pinocytosis (cell drinking) [Mel96]. Phagocytosis is restricted to
specialized cells such as leukocytes, whereas pinocytosis occurs in all cell types.
The process of pinocytosis is subdivided into macropinocytosis a non selective
endocytotic mechanism, clathrin-dependent (CDE) and clathrin-independent
(CIE) endocytosis [Rej+04; Jon07]. In order to determine what route of the
dendriplexes take into a cell I applied different drugs known to inhibit various
endocytotic pathways.
Cytotoxicity of Endocytosis Inhibitors
The cell toxicity of most of the commonly used endocytosis inhibitors is highly
dependent on the cell type [Ver+09]. Furthermore the concentration window
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between the specific inhibition and the non-specific toxicity of the uptake
inhibitors is very narrow [Ger+06]. To ensure cell viability during uptake and
transport I performed a potential short-term cytotoxicity assay of seven cho-
sen inhibitors in HeLa cells. Chemical inhibitors were prepared at a range
of concentration known to reduce dynamin-dependent endocytosis (Dyna-
sore 80µm- 160µm) [Mac+06; Tsa+09; Chu+09], clathrin-mediated endocytosis
(Chlorpromazine 14µm-25µm [Per+11; SB06; GSK04], phenyl-arsine oxide
(PAO) 1µm- 20µm [Gib+89; Yum+06]), lipid raft/caveolae-mediated endocy-
tosis (Methyl-β-cyclodextrin (MβCD) 1mm-10mm [Roe+02; ZBF09; AWC10])
and inhibitors of macropinocytosis and phagocytosis (Cytochalasin D (CytoD)
1µm- 10µm [PM02; Iva08], Nocodazole 20µm-60µm [Mue02; Bar+05; Dau+08],
Latrunculin A 1µm-10µm [OM88; Fuj+00; Wei04]). Cytotoxicity of the selected
inhibitors was assessed by Trypan Blue exclusion assay. HeLa cells were seeded
on IBIDI µ-Slide with 8 wells with a density of 2.104 cells/well andmaintained
in normal grow medium for 48 h at 37 ◦C (subsection 3.2.1). The medium was
then replaced with fresh OPTIMEM serum reduced transfection medium
containing the chosen inhibitors at various concentrations. After 2 h, the in-
hibitor solutions were removed and a Trypan Blue cell viability assay was
performed. Five of the seven chosen inhibitors of endocytosis appear not to
influence the viability of HeLa cells in the applied concentration range. We
observed over 95% viable cells by applying chlorpromazine, cytochalasin D,
Dynasore, Methyl-β-cyclodextrin and Nocodazole (Figure 2.20). On the other
hand, Phenyl-arsine oxide (PAO ) and Latrunculin A (LatA) showed significant
toxicity over the range of concentrations tested and consequently were not be
used for future dendriplex uptake studies.
Influence of the Clathrin Pathway
The clathrin-dependent endocytosis pathway is one of the most extensively
studied endocytosis mechanism which is thought to be the preferred uptake
pathway for microspheres of up to 200 nmwhich resemble the dendriplex size
[Rej+04; HYR10]. As a first step to determine the dendriplexes uptake mech-
anism I introduced Chlorpromazine, a cationic amphipathic drug known to
inhibit the clathrin-coated pit formation by a reversible translocation of clathrin
from the plasma membrane to intracellular vesicles [WRA93; SB06]. Consider-
ing the statistics of the dendriplex formation between the Np4Atto550 peptide
dendrimer and a plasmid DNA (pmaxGFP) with a size of 4.7 kbp (section 2.3)
I chose this system to investigate the cellular uptake of the above mentioned
dendriplex for three different Chlorpromazine concentrations: 14µm, 20µm
and 25µm. Dendriplex formation was carried out in double distilled water at
room temperature using a N/P ratio of 5 and a plasmid DNA concentration
of 1µg per well. This value was chosen during preliminary experiments (sec-
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Figure 2.20: Comparison of the cytotoxicity of endocytosis inhibitors applied
for the cellular uptake studies of the peptide dendriplexes. Control means only
cells without inhibitor. Methyl-β-cyclodextrin (MβCD), Phenyl-arsine oxide
(PAO). Results are reported asmean value from three independent experiments
±SD.
tion 2.4.3) as it provided the highest level of cell viability. Larger amounts of
plasmid DNA implied the use of higher dendrimer concentrations, and conse-
quently decreased cellular viability. HeLa cells were seeded on IBIDI µ-Slide
with 8 wells at a density of 2.104 cells/well and maintained in normal grow
medium for 48 h at 37 ◦C to allow attachment (subsection 3.2.1). Cells were
then washed with Phosphate Buffered Saline (PBS) and pretreated with the
required amount of Chlorpromazine in OPTIMEM serum reduced medium
for 30min. Dendriplexes were added in the presence of the inhibitor for two
hours at 37 ◦C. The uptake experiments were performed for only two hours
because blocking the route of uptake might lead to an activation of other endo-
cytotic pathways [Dam+95; Har+07]. The inhibition of the dendriplex cell entry
was determined by laser scanning microscopy and quantified using ImageJ
software. As shown in (Figure 2.21 (a)) Chlorpromazine significantly effects
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Figure 2.21: Effect of chlorpromazine on the cellular uptake of fluores-
cent Np4Atto550-pmaxGFP peptide dendriplexes (a) Intracellular uptake of
Np4Atto550-pmaxGFP dendriplex in HeLa cells after chlorpromazine treat-
ment. A) Negative control-no inhibitor, B) 14µm Chlorpromazine, C) 20µm
Chlorpromazine, D) 25µm Chlorpromazine. The cell membranes were stained
with CellMask Deep Red corresponds to the red channel. The green chan-
nel represents the fluorescent dendriplex. Scale bars 15µm. (b) Inhibition of
the relative fluorescence of Np4Atto550-pmaxGFP peptide dendriplexes by
chlorpromazine. Results are reported as mean value from three independent
experiments ±SD.
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the cellular uptake of the dendriplex. I observed reduced cellular distribution
of the fluorescent Np4Atto550-pmaxGFP dendriplex after chlorpromazine
treatment. The dendriplex cellular uptake at a chlorpromazine concentration
of 14µm shows a reduction of approximately 45% and much higher degree
of inhibition by applying 20µm and 25µm chlorpromazine. This leads to the
conclusion that clathrin-dependent endocytosis plays a major role during the
uptake of positively charged dendriplexes. Chlorpromazine which disrupt
clathrin assembly and disassembly reduces the dendriplex uptake by more
than 80% at a concentration of 25µm (see Figure 2.21 (b)).
Dynamin is Involved in the Dendriplex Uptake
As mentioned above the clathrin-mediated pathway remarkably influences
the dendriplex cell entry. A fundamental step in this endocytosis process is
the fission of clathrin-coated pits from the plasma membrane. Essential for
release of a complete vesicle is a cytosolic protein called dynamin which poly-
merizes around the neck of the vesicle [Dam+01; PM04]. The energy derived
from this process is responsible for a conformation change in dynamin that
stretches the vesicle until they pinch off [Lod00]. As a result consequently
dynamin is thought to play an important role in clathrin-mediated endocy-
tosis and to be involved in several lipid raft-mediated processes [KP05]. In
order to examine whether dynamin-mediated endocytosis is involved in the
entry route of dendriplex in to HeLa cells I used a specific cell-permeable
dynamin inhibitor dynasore which blocked the GTPase activity of dynamin
and prevent its conformational changes [Mar+01]. Dynasore was applied in
two different concentrations 80µm and 160µm providing maximal cell via-
bility (Figure 2.20). Prior to inhibitor treatment HeLa cells were seeded on
IBIDI µ-Slide with 8 wells with a density of 2.104 cells/ml and maintained
in normal grow medium for 48 h at 37 ◦C to allow attachment. Cells were
washed with Phosphate Buffered Saline (PBS) and pretreated with the re-
quired amount Dynasore in OPTIMEM serum reduced medium for 30min.
Dendriplexes were prepared in double distilled water at a N/P ratio of 5 and
then added to the cells in the presence of the inhibitor for two hours at 37 ◦C.
The amount of plasmid DNA was kept constant at 1µg per well. I chose to
shorten the incubation time to prevent activation of non specific endocytosis
pathways. The inhibition of the dendriplex cell entry was determined by laser
scanning microscopy. The endocytosis and intracellular accumulation of pep-
tide dendriplex (Np4Att0550-pmaxGFP) were strongly blocked by dynasore
(Figure 2.22 (a)) indicating that uptake of these fluorescent dendriplexes is
highly dependent on dynamin. Even then using a lower dynamin concen-
tration of 80µm the dendriplex cellular uptake was reduced by almost 90%.
Applying a concentration of 160µm induce almost complete inhibition of the
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Figure 2.22: Effect of dynasore on the uptake of fluorescent Np4 dendriplexes.
(a) Fluorescent microscope images A) Negative control means no inhibitor,
B) 80µm Dynasore, C) 160µm Dynasore. The cell membranes were stained
with CellMask Deep Red corresponds to the red channel. The green chan-
nel represents the fluorescent dendriplex (Np4Atto550-pmaxGFP). Scale bar
corresponds to 15µm. (b) Inhibition of the Np4Atto550-pmaxGFP total cell
fluorescence in HeLa cells after dynasore treatment. Results are reported as
mean value of three independent experiments ±SD.
70 CHAPTER 2. EXPERIMENTS AND RESULTS
dendriplex endocytosis ( see Figure 2.22 (b)).
Dendriplex Uptake does not Includes Lipid Raft/Caveolae-Mediated
Pathway
After investigating the involvement of the clathrin-mediated endocytosis in
the dendriplex uptake mechanism, I will determine whether the clathrin-
independent endocytosis pathway is present as well. Endocytosis mediated by
caveolae and glycolipid rafts belongs to the clathrin-independent endocytosis
(CIE) mechanisms [PEL08]. This endocytotic process plays an important role
for the uptake of certain pathogenes and toxins and is involved in the internal-
ization of some plasma membrane lipids and proteins [Nab03; Vas+08]. The
clathrin-independent pathway is induced by specific ligands such as cholera
toxin and is considered to be the predominant pathway of entry for particles
above 200 nm [Rej+04; Dam+05]. A rich collection of literature suggests inhibi-
tion of lipid/raft caveolae-mediated endocytosis by cholesterol depletion in
the plasma membrane [SA02; GRA+04]. In order to study the contribution of
lipid raft/caveolae-mediated endocytosis to the cellular uptake of the peptide
dendriplex I employed methyl-β-cyclodextrin (MβCD) a widely used inhibitor
containing hydrophobic core with high affinity for cholesterol [Roe+02; Iva08;
ZBF09]. MβCD was applied in three different concentrations 1mm, 4mm and
10mm providing minimal cell toxicity (Figure 2.20) by maximal cholesterol
depletion. Prior to the inhibition treatment HeLa cells were seeded on IBIDI
µ-Slide with 8 wells with a density of 2.104 cells/well and maintained in nor-
mal grow medium for 48 h at 37 ◦C to allow attachment. Cells were pretreated
with the required amount of MβCD in OPTIMEM serum reduced medium for
30min. Peptide dendriplexes were prepared in double distilled water like de-
scribed in (subsection 3.3.5) at aN/P ratio of 5 and then added to the cells in the
presence of the inhibitor for two hours at 37 ◦C. The amount of plasmid DNA
was kept constant at 1µg per well. To prevent the activation of non specific
endocytosis pathways I chose a shorter incubation time. The inhibition of the
dendriplex cell entry was determined by laser scanning microscopy and quan-
tified using the public domain ImageJ software. Lipid raft/caveolae-mediated
endocytosis seems not to be involved in the peptide dendriplex cell entrymech-
anism (Figure 2.23 (a)). The intensity of the green fluorescence representing
the dendriplex (Np4Atto550-pmaxGFP) inside the cells remains constant even
by using higher MβCD concentrations. Unfortunately cholesterol depletion
is not a very specific inhibition for lipid raft-dependent endocytosis because
the clathrin pathway and macropinocytosis may also be deranged [Nic03;
Rej+04]. Puri et al. [Pur01] reported that Methyl-β-cyclodextrin treatment re-
duced the cellular cholesterol by approximately 75%. However, cholesterol
depletion was not complete but nevertheless seems not to be involved in the
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Figure 2.23: Uptake of fluorescent peptide dendriplex after cholesterol de-
pletion via MβCD. (a) Fluorescent microscope images A) Negative control
means no inhibitor, B) 1mm MβCD, C) 4mm MβCD, D) 10mm MβCD. The
cell membranes were stained with CellMask Deep Red corresponds to the red
channel. The green channel represents the fluorescent dendriplex (Np4Atto550-
pmaxGFP). Scale bar corresponds to 15µm. (b) Total cell fluorescence of the
Np4Atto550-pmaxGFP dendriplexes in HeLa cells after MβCD treatment.
Results are reported as mean value of three independent experiments ±SD.
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dendriplexes uptake. As shown in Figure 2.23 (b) even by applying higher
MβCD concentration of (10mm) the uptake of the fluorescent dendriplexes
remains unaffected.
Role of F-Actin and Microtubules
Certain components of the cytoskeleton are involved in the endocytosis and in
the traffic of endocytotic vesicles [Lam97; Pen+97]. The cytoskeleton of eucary-
otic cells consists of three different kinds of protein filaments: actin, tubulin
and intermediate filaments and provides cell structure [Alb02]. In order to
estimate the role of F-actin and microtubules in the uptake of the peptide
dendriplex into HeLa cells I introduced Cytochalasin D (CytoD) as an actin
polymerization inhibitor and Nocodazole as microtubules disassembly pro-
moter. Cytochalasin D blocks actin polymerization by increasing the number
of actin filament ends and formation of filamentous aggregates [Sch82] and
therefore affects both phagocytosis and pinocytosis [QK02].
Based on the results of the endocytosis inhibitors cytotoxicity studies (sec-
tion 2.4.4) I chose two different concentrations of Cytochalasin D 4µm and
10µm to investigate the effect of F-actin polymerization inhibition on the pep-
tide dendriplex uptake. This experiment was performed as described above
with a constant amount of plasmid DNA at 1µg per well. In order to prevent
activation of non specific endocytosis pathways I implement a shorter incu-
bation time. The inhibition of the dendriplex cell entry was determined by
laser scanning microscopy and quantified by using ImageJ software. As seen
in Figure 2.24 (a) it is obvious that the disassembly of the actin cytoskeleton
does not inhibit the cellular entry of the peptide dendriplex. The intracellular
distribution of the fluorescent dendriplex (green channel) remains unaffected
by cytochalasin D treatment. F-actin polymerization disruption by cytocha-
lasin D does not affect the cellular uptake of fluorescent dendriplexes into
HeLa cells. Even by applying a higher concentration of 10µm cytochalasin D
the dendriplex cellular uptake is still almost 100% (Figure 2.24 (b)). Therefore
I demonstrated that peptide dendriplex internalization is not dependent on
F-actin.
In order to examine the influence of microtubules on dendriplex internal-
ization by HeLa cells nocodazole was used as a microtubules disrupting agent
[Bar+05]. Considering the inhibitors cytotoxicity studies ( section 2.4.4) I chose
two different concentration of nocodazole 30µm and 60µm to investigate the
role of microtubules on the peptide dendriplex uptake in HeLa cells.
The dendriplex formation as well as the cell preparation was performed
as described in chapter 3. The required amount of nocodazole in OPTIMEM
serum reduced medium was then added to the cells and incubated for 30min.
Dendriplexes containingNp4Atto550 peptide dendrimer and a constant amount
2.4. PEPTIDE DENDRIMERS AS DNA DELIVERY VECTORS 73
Figure 2.24: (a) Intracellular distribution of fluorescent peptide dendriplex
into HeLa cells after inhibiting the function of F-actin by cytochalasin D. A)
Negative control no inhibitor, B) 4µm cytochalasin D, C) 10µm cytochalasin
D. The cell membranes were stained with CellMask Deep Red corresponds
to the red channel. The green channel represents the fluorescent dendriplex
(Np4Atto550-pmaxGFP). Scale bar corresponds to 15µm, (b) Relative fluores-
cence of Np4Atto550-pmaxGFP dendriplexes into HeLa cells after cytochalasin
D treatment. Results are reported as mean value from three independent ex-
periments ±SD.
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of 1µg per well plasmid DNA (pmaxGFP) were added to the cells in the pres-
ence of the inhibitor for 2 h at 37 ◦C. To avoid activation of non specific en-
docytosis pathways I implement a shorter incubation time. The influence of
the microtubules disrupting agent nocodazole of the dendriplex uptake was
determined by laser scanning microscopy and quantified using the ImageJ
software.
Figure 2.25: (a) Moderate reduction of the cell entry of fluorescent peptide den-
driplexes into HeLa cells after nocodazole treatment. A) Negative control no
inhibitor, B) 30µm nocodazole, C) 60µm nocodazole. The cell membranes were
stained with CellMask Deep Red corresponds to the red channel. The green
channel represents the fluorescent dendriplex (Np4Atto550-pmaxGFP). Scale
bar corresponds to 15µm, (b) Relative fluorescence of Np4Atto550-pmaxGFP
dendriplexes into HeLa cells after nocodazole treatment. Results are reported
as mean values from three independent experiments ±SD.
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The effect of this treatment was stronger than with actin de-polymerization
drugs however the (Figure 2.25 (a)) shows. Nocodazole was found to inhibit
endocytosis of peptide dendriplexes to about 50% at a concentration of 60µm
(Figure 2.13 (b)). These results suggest that microtubules are involved in the
uptake of peptide dendriplexes.
Figure 2.26: Effect of different endocytosis inhibitors on the cellular uptake of
fluorescent peptide dendriplexes. Results are reported as the percentage of
uptake relative to untreated cells exposed to Np4Atto550-pmaxGFP peptide
dendriplex. Values are given as mean ±SD (n=3).
Peptide dendriplexes show a remarkable reduction in cellular uptake in
the presence of chlorpromazine, dynasore and nocodazole (Figure 2.26), sug-
gesting the involvement of both clathrin-dependent and clathrin-independent
endocytosis pathways in the dendriplex cell entry mechanism. The greatest
reduction in the dendriplex uptake was determined in the presence of dyna-
sore, a selective chemical inhibitor of dynamin, a protein essential for vesicle
pinching from the plasma membrane during clathrin-mediated endocytosis.
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The significant decrease in uptake of dendriplexes in the presence of dyna-
sore confirms the endocytosis of the Np4Atto550-pmaxGFP dendriplex by
dynamin-dependent pathways. In contrast, dendriplexes does not show a re-
duced uptake in the presence of cytochalasin D and a negligibly low reduction
in the presence of methyl-β-cyclodextrin, which leads to the conclusion that
the actin cytoskeleton and lipid rafts/caveolae are not involved in the cellular
uptake mechanism of the Np4Atto550-pmaxGFP dendriplex. Microtubules
are involved in the cellular uptake of the peptide dendriplexes into HeLa cells.
Intracellular Trafficking of Peptide Dendriplexes in Human Cervix
Carcinoma Cells
Optimisation and improvement of the efficiency of transfection mediated by
dendrimers needs a deep understanding of the mechanisms of intracellular
trafficking by these complexes. In addition to determining the mechanism of
uptake I investigate the intracellular trafficking of the peptide dendriplexes in
HeLa cells using lysosomes and mitochondria markers. This experiment was
performed by seeding HeLa cells on IBIDI µ-Slide with 8 wells at a density of
2.104 cells/ml. The cells were maintained in normal grow medium for 48 h
at 37 ◦C to allow attachment. Cells were washed with Phosphate Buffered
Saline (PBS) and the grow medium was relapsed with OPTIMEM serum
reduced medium. Dendriplexes containing Np4Atto550 peptide dendrimer
and a plasmid DNA (pmaxGFP) with a size of 4.7 kbp were prepared at a
N/P ratio of 5 in double distilled water and then added to the cells. After
an incubation of 1 h at 37 ◦C, 50 nm LysoTracker® Red DND-99 or 100 nm
MitoTracker®Deep Red FM respectively was added and incubated for another
30min. The trafficking of the dendriplexes was determined by laser scanning
microscopy. Colocalization between Np4Atto550-pmaxGFP dendriplex with
lysosomes and mitochondria was quantified using the ImageJ software.
It was found that peptide dendriplexes were trafficked to the lysosomes af-
ter 30min. Dendriplexes that are colocalized with the endosomes/lysosomes
appear yellow in Figure 2.27. A Pearson’s correlation coefficient value between
0.5 and 1 indicate colocalization while values between -1 and 0.5 indicate no
colocalization [ZZO07]. High colocalization of both biomarkers was observed
with Np4Atto550-pmaxGFP dendriplex (Pearson’s correlation coefficient >0,5
) (see Table 2.1). The colocalization of the peptide dendriplexes with the lyso-
somes is better as the one with the mitochondria.
In summary, it can be said that due to their low pH (between 5.5-6.5)
fluorescent peptide dendriplexes are mainly localized into the lysosomes and
partially into the mitochondria. Pearson’s correlation coefficient and overlap
coefficient for the lysosomes colocalization have higher values as this for the
mitochondria.
2.4. PEPTIDE DENDRIMERS AS DNA DELIVERY VECTORS 77
Figure 2.27: Intracellular trafficking of fluorescent dendriplex in to HeLa cells.
A) Colocalization with lysosomes is shown were acidic endolysosomal com-
partments are stained with LysoTracker® Red DND-99. B) Colocalization
with mitochondria is shown were this compartments are stained with Mito-
Tracker® Deep Red FM. The green channel represents the fluorescent den-
driplex (Np4Atto550-pmaxGFP) and the red channel LysoTracker, respectively
MitoTracker. The colocalization of dendriplexes and lysosomes, mitochondria
respectively appears in yellow. Scale bar corresponds to 15µm.
Boimarker Overlap coefficient Pearson’s correlation coefficient
LysoTracker® Red
DND-99
0.91 0.86
MitoTracker®
Deep Red FM
0.62 0.78
Table 2.1: Colocalization of fluorescent labelled Np4-pmaxGFP dendriplexes
with lysosomes and mitochondria.

Chapter 3
Materials and Methods
In this chapter the materials, instruments and fundamental procedures used
in this work are introduced.
3.1 Materials and Reagents
3.1.1 Fluorofores
Two different organic fluorescent dye were applied in this work for DNA and
peptide dendrimer labelling. Atto550 (Atto-Tek, Siegen) was chosen for the
peptide dendrimer labelling andAtto655 (Atto-Tek, Siegen) for theDNA/Oligo-
nucleotide. These dyes were purchased as N-Hydroxysuccinimid (NHS)-esters.
The solid esters were then dissolved inN,N-Dimethylformamide (DMF, puriss.,
absolut, over molecular sieve, Sigma-Aldrich, Steinheim) at 2mgml−1 and
stored at −20 ◦C for several months. The main fluorophore properties are
listed in Table 3.1.
Dye λabs,max[nm] λem,max[nm] τ f [ns] Φ f [%] [1× 105 m−1 cm−1]
Atto550 554 576 3.6 80 1.2
Atto655 663 684 1.25 65 1.25
Table 3.1: Properties of the organic fluorophores used in this work
3.1.2 Oligonucleotides
All oligonucleotides (oligos) used in this work were purchased custom syn-
thesized, (labelled with Atto 655 fluorescent dye) and high pressure liquid
chromatography (HPLC) purified (Sigma Aldrich, Taufkirchen, Germany un-
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less stated otherwise). They were delivered as lyophilized powder and were
dissolved before use in filtered double distilled sterile water at pH 7.0 and
stored at −20 ◦C for up to two weeks. The sequences of the used oligonu-
cleotides are listed in Table 3.2.
Oligo Name Sequence (3’ to 5’) Comment
Oligo (O) CCATCCCGACCTCG
CGCTCC
5’-Atto655
Large Oligo (L) CCATCCCGACCTCG
CGCTCCATCCCGAC
CTCGCGCTCC
5’-Atto655
Extra Large Oligo (XL) CCATCCCGACCTCG
CGCTCCATCCCGAC
CTCGCGCTCCACCA
TCCCGACCTCGCGC
TCC
5’-Atto655
Extra Extra Large Oligo
(XXL)
CCATCCCGACCTCG
CGCTCCATCCCGAC
CTCGCGCTCCACCA
TCCCGACCTCGCGC
TCCACCATCCCGAC
CTCGCGCTCC
5’-Atto655
Table 3.2: Oligonucleotides
3.1.3 Dendrimers
The peptide dendrimers were synthesized using the well established Solid
Phase Peptide Synthesis (SPPS) method (see section 3.3 for more information).
The dendrimer structures are represented below (Figure 3.1 and Figure 3.2).
3.1.4 Plasmids
Plasmid DNA pmaxGFP (4.7 kbp) containing the pmaxFP-Green-N vector en-
coding the green fluorescent protein ant the CMV IE promoter was purchased
from Lonza Group Ltd., Switzerland.
3.1.5 Buffers and Solutions
The compositions of all the buffers and solutions used through this work are
listed below (Table 3.3). They were mostly prepared in the laboratory and
sterile filtered before use.
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Figure 3.1: Chemical structures of the Np3 and the Np4 peptide dendrimers.
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Figure 3.2: Chemical structures of the Np5 and the Np6 peptide dendrimers.
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Table 3.3: Buffers And Solutions
Buffer/ Reagents Contents Comments
phosphate buffered
saline (PBS)
0.01m phosphate
buffer, 2.7mmKCl and
137mm NaCl, pH 7.4,
at 24 ◦C
from tablets or Dul-
becco’s PBS, liquid;
both Sigma-Aldrich,
Taufkirchen
Tris-Glycine Buffer 25mm Tris base,
192mm glycine pH 8.3,
at 24 ◦C
Tris-EDTA Buffer 10mm Tris base, 1mm
EDTA pH 7.5, at 24 ◦C
1X sample buffer (w/
bromphenolblue)
31mm Tris-HCl, 20%
glycerol (0.005%
bromphenolblue)
Carbonate Buffer 10ml of 0.1mm
sodium carbonate
solution mixed with
115ml of 0.1mm
sodium hydrogen
carbonate solution pH
9.0, at 24 ◦C
375ml double dis-
tilled water was added
as to get a final volume
of 500ml
Phosphate Buffer 28ml of 1mm
NaH2PO4 solution
mixed with 72ml
of 1mm Na2HPO4
solution pH 7.2, at
24 ◦C
900ml double dis-
tilled water was added
as to get a final volume
of 1000ml
Lysogeny Broth (LB)
Medium
10 gl BactoTrypton,
5 gl YastExtract,
10 gl NaCl,
autoclave before use
Lysogeny Broth (LB)
Agar
10 gl BactoTrypton,
5 gl YastExtract,
10 gl NaCl, 15
g
l Agar
autoclave before use
Ampicillin (Amp)
Stock
100mgml store at −20 ◦C
Kanamicyn (Kan)
Stock
50mgml store at −20 ◦C
Tris-Acetate-EDTA
(TAE) Buffer
40mm Tris base (pH
7.6), 20mm acetic acid,
1mm EDTA
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Figure 3.3: Map of the plasmid DNA pmaxGFP.
3.1.6 Other Materials
Cell culture dishes, flasks and 6-well plates from Greiner Bio-one, Germany.
Cuvettes for UV/Vis and fluorescence measurements; SUPRASIL quartz grass
semi-micro cuvettes (Helma,Muelheim). 8wellsµ-Slide for transfection experi-
ments-IBIDI, Germany. Micro-tubes from Axygen, USA.
3.2 Methods
3.2.1 Cell Culture and Transfection Methods
Human cervix carcinoma (HeLa) and mouse embryonic fibroblast which ex-
press Erythropoietin (Epo) receptor (NIH3T3 EpoR) cells lines were obtained
from DSMZ-German Collection of Micro-organism and Cell Culture and cul-
tured according to standard mammalian tissue culture protocols and sterile
technique at 37 ◦C in 5% CO2 The cells were cultured in Dulbecco‘s Mod-
ified Eagle Medium medium (DMEM) purchased from Live Technologies,
Germany. All media was supplemented with 10% Foetal Bovine Serum (FBS),
100 units/ml penicillin 100µgml−1 streptomycin. All tissue culture media
and supplements were obtained from Life Technologies, Germany. For all the
transfection experiments cells were seeded on IBIDI µ-Slide with 8 wells (Ibidi
GmbH, Martinsried, Germany) with a density of 2.104 cells/ml and cultured
in 300µl of complete medium for 48 h to allow attachment. On the day of the
transfection the cells were washed twice with Phosphate Buffered Saline (PBS)
(Sigma Aldrich, Germany) and the dendriplexes diluted in OPTIMEM serum
reduced media total volume 200µl were added to the cells and incubated for
4 h respectively 3 h for the HeLa cell line at 37 ◦C. After transfection the cells
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were washed twice with Phosphate Buffered Saline (PBS). 200µl of Leibovitz
L-15 (Live Technologies, Germany) medium was added and the cells were im-
aged at SP5X laser scanning microscope (Leica Microsystems GmbH, Wetzlar,
Germany).
3.2.2 Electrophoretic Mobility Shift Assays (EMSA)
The gel electrophoresis mobility shift assay (EMSA) is used to determine
the complexes formation between peptide dendrimers and nucleic acids od
different size at different charge ratios.
Agarose Gel Electrophoresis
Agarose gel electrophoresis assay was performed to investigate the dendriplex
formation. Complex formation of plasmid DNA (pmax GFP 4.7 kbp) and four
peptide dendrimers 4+Np3, 8+Np4, 4+Np5 and 8+Np6 was examined by the
electrophoretic mobility of the complex on agarose gel stained with ethidium
bromide at the various ratios of dendrimer to plasmid DNA. The dendriplexes
were prepared as describe in subsection 3.3.5 using 1µg of plasmid DNA. Gel
electrophoresis sample buffer (subsection 3.1.5) was added to each sample
and it was electrophoresed on 1% agarose gel (prepared from 1 g of low
melting agarose (Sigma-Aldrich, Germany) in 100ml of 1 X Tris-Acetate-EDTA
(TAE) buffer) for 180min at 80W constant power. Gels were then stained with
1µgml−1 ethidium bromide for 30min and illuminated with UV illuminator
(Intas Ge iX Imager, Royal Biotech GmbH, Germany) to show the location of
the DNA. A 1 kbp ladder (Life Technologies, Germany) was used as a size
marker.
Polyacrylamide Gel Electrophoresis
For more sensitive dendriplex detection by using smaller DNA (20, 38, 62, 83
base) polyacrilamide gel electrophoresis assay (PAGE) was applied. In general,
peptide dendrimer-nucleic acid complexes migrate more slowly than the cor-
responding free DNA. Native 0.75mm thick 12% polyacrilamide gel without
sodium dodecyl sulphate (SDS) (see Table 3.4) was prepared as described in
[Lae70; HF07] and used for the dendriplex detection. The gels are prerun in 1X
Tris-Glycine running buffer subsection 3.1.5 for at least 5min at 80W constant
power. 10µl sample is added to each gel pocket, empty lanes are supplied with
1X sample buffer and bromphenolblue to visualize the front. Electrophoresis
was performed at room temperature (22 ◦C) in a vertical mini-gel system (Mini-
Protean II, Bio-Rad, Hercules, CA, USA) at a constant 80W constant power for
2-2.5 hours until the tracking dye approached the lower gel margin. Gels are
intermediately imaged with a gel scanner (Odyssey, Li-Cor, Bad Homburg).
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Reagent Amount
dd H2O 10.2ml
30% Acryamide 12ml
1,5M Tris (pH 8.3) 7.5ml
10% APS 300µl
TEMED 12µl
Table 3.4: Mix for 12%Native Polyacrilamide Gel
3.3 Protocols
3.3.1 Synthesis of the
[8+(Arg)4-(Lys)3-(Gly)2-(Lys)-(Cys-Npys)-Gly-NH2] (Np4)
Peptide Dendrimer
The peptide dendrimer was synthesised in collaboration with Dr. Harendra
Pahrek, School of Pharmacy University of Queensland, Brisbane by using
the well known Solid Phase Peptide Synthesis (SPPS) method [Che+04]. The
synthesis procedures are described in Table 3.5. All the used reagents were
high pressure liquid chromatography (HPLC) purified purchased fromMerck,
Novabiochem, Australia and stored in a desiccator for 24 h to remove possible
existing moisture.
3.3.2 Ninhydrin Test
The Ninhydrin (2,2-Dihydroxyindane-1,3-dione) was used to detect ammonia
or primary and secondary amines [Sar+81]. In presence of free amines a deep
blue or purple colour known as Ruhemann’s purple is produced (Figure 3.4).
The ninhydrin test (all reagents were purchased from Sigma-Aldrich, Australia)
was carried out on a 1mg of resin taken from the reaction vessel. The resin
was filtered and washed twice with 50/50 DCM/MeOH, then dried under
vacuum. To a dry, weighed resin sample in a test tube, the following reagent
was added: 2 drops reagent 1, 4 drops reagent 2; 2 drops reagent 3 (Table 3.6).
The mixture was then incubated for 5min at 100 ◦C by using a dry block
heater. Afterwards, 2.8mlof 60% ethanol in water solution was added and
absorbance at 570 nm against a reagent blank was measured using a Varian
Cary Eclipce Fluorescence Spectrophotometer. The reagent blank was treated
in the same manner as the sample except that there is no resin in the tube. The
ninhydrin value (NV) and the percentage of coupling yield was calculated as
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Table 3.5: Protocol for the Np4 Peptide Dendrimer Synthesis
Protocol Time
Resin Amide 0.7mMg , used (0.5mm), 0.714 g swelling in
DMF (soak resin in DMF until saturated)
60min
Resin Fmoc removal. Incubate resin with 20% v/v piperi-
dine in DMF and agitate
2 X 8min
DMF wash and then drain under vacuum 8-10 times
Amino acid coupling Fmoc-Gly-OH (2mm, 0.595 g) in
DMF)
120min
Add activation reagents
HBTU (2mm,4ml), respective for future amino acids
DIPEA(2mm,347µl), respective for future amino acids
Ninhydrin test
DMF wash and then drain under vacuum 8-10 times
Repeat amino acid coupling for:
Fmoc-Lys(Dde)-OH (2mm, 1.065 g)
Fmoc-Gly-OH (2mm, 0.595 g)
Fmoc-Gly-OH (2mm, 0.595 g)
Fmoc-Lys(Fmoc)-OH (2mm, 1.181 g)
Fmoc-Lys(Fmoc)-OH (4mm, 2.361 g)
Fmoc-Arg(Pbf)-OH (8mm, 5.1904 g)
Cleavage of the Dde-OH with NH2OH.HCl-imidazole
in NPM
60min
Repeat amino acid coupling for:
Fmoc-Cys(Trt)-OH (4mm, 2.342 g)
DMF wash and then drain under vacuum 8-10 times
Resin drying in vacuo 22 h overnight
TFA cleavage off-resin 180min
TFA/TIPS/H2O/DCM-90:2.5:2.5:5
DTNP (5mm, 1.551 g)
Filter solution
Evaporate TFA 60min
Azeotrope with toluene 3 X 15ml
Triturate with cold diethyl ether 5 X 10ml
Dissolve residue in water and lyophilize 24 h
The crude product after lyophilization was analyzed by
MS and purified by prep RP-HPLC
Re-analysed by MS and analytical RP-HPLC
Pure fractions were then lyophilized
Yield= 0.0057 g (57%)
RP-HPLC Rt = 12.97min
ESI+ −MSm/z calculated for
(C62H117N31O14S2): 1582.91;
found 1583.00 [M+ H]+
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Figure 3.4: Two molecules of Ninhydrin reacted in alkaline mediumwith short
peptide to Ruhemann’s purple.
Table 3.6: Reagents for Ninhydrin Test
Reagent Contents Comments
Reagent 1 76% w/w Phelon in
Ethanol
stir to dissolve. Store in
a dark bottle
Reagent 2 0.2mm KCN in Pyri-
dine
dissolve KCN in small
quantity of water, then
fill up to 100ml with
pyridine. Store in a dark
bottle.
Reagent 3 0.28m Ninhydrin in
ethanol
dissolve ninhydrin in
ethanol using an ultra-
sonic bath
following:( see Equation 3.1 and Equation 3.2).
NV = absorbance at 570 nm x 200
weight (mg)
(3.1)
Coupling = (1-(ninhydrin value (NV))
substitution value (SV, mMg )
x 100 (3.2)
3.3.3 Dendrimer Labelling
Fluorescent dye Atto550 purchased from ATTO-TEC GmbH, Germany as a
NHS-ester was dissolved in N,N Dimethylformamide (DMF, puriss., absolute,
over molecular sieve, Sigma-Aldrich, Steinheim) at 2mgml−1 and stored at
−20 ◦C. 100 nm of Atto550 fluorescent dye was mixed with 1mm of cystein
(Sigma-Aldrich, Germany) in 100µl of carbonate buffer pH 9.0 (section 3.3)
and shaken for 3 h at 30 ◦C using a thermo shaker(Thermomixer comfort,
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Eppendorf, Germany). 100 nm of the Np4 peptide dendrimer synthesized
as describe in subsection 3.1.3 were then added to the reaction mixture and
shaken for another 3 h at 30 ◦C. The Np4 peptide dendrimer was dissolved in
fresh sterile double distilled water intermediately before labelling procedure
in a concentration of 1mgml−1.
3.3.4 Purification of the Labelled Np4 Peptide Dendrimer
After the labelling reactionwas completed the fluorescent labelled peptide den-
drimer (Np4Atto550) was purified by using a Slide-A-Lyzer Dialysis Cassettes
to remove the free dye and non reacted reagents. Therefore 200µl of the reac-
tion mixture was injected into the dialysis cassette (Slid-A-Lyzer, MWCO 2000;
Thermo Fischer Scientific, Germany) and dialysed for 2 h against phosphate
buffer (subsection 3.1.5) pH 7.2, then the buffer was replaced with a fresh clean
one and dialysed overnight. At the next day the solution was removed from
the dialysis cassette and the concentration of the labelled peptide dendrimer
(Np4Atto550) in solution was determined by measuring the UV absorption
at 554 nm. Afterwards, the solution was placed into a Vacuum Concentrator
(Eppendorf, Germany) for draying. The solid substance was then diluted in
sterile double distilled water in a concentration of 1mgml−1 and stored at
−20 ◦C for up to two weeks.
3.3.5 Dendriplex Preparation
Fluorescently labelled as well unlabelled peptide dendrimers Np3, Np4, Np5,
Np6 (structures see Figure 3.1 and Figure 3.2) were used in a concentration
of 1mgml−1. All the solutions were prepared intermediately before the ex-
periment by using fresh double distilled sterile water pH 7.0. Dendriplexes
were formed by mixing of the peptide dendrimers (using a vortexer) with the
DNA (stock solution 10 nm) in 10µl of fresh double distilled sterile water pH
7.0 and incubation for 30min at room temperature. Ratios of nucleic acid to
dendrimer were based on the calculation of the electrostatic charges present
on each component; e.g., the number of phosphate groups in the nucleic acid
vs. the number of terminal amine groups on the dendrimer. Dendriplexes with
a N/P ratio of 0.6, 1, 2, 3, 5, 10 and 20 were prepared.
3.3.6 Oligonucleotides Hybridization
The oligonucleotide hybridization reactions are carried out in a total volume
of 60µl in sterile filtered Phosphate Buffered Saline (PBS) by using a 500µl
reaction tube so that the temperature in the solution quickly reached the
thermocycler temperature. To ensure that all labelled oligonucleotides are
hybridized an excess of 1.1: 1 of unlabelled to labelled ssDNA was used. After
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pipetting, the solutions are mixed gently by pipetting up and down several
times, spun down and placed in the thermocycler (PTC-100, MJ Research,
Waltham, USA). Hybridization proceeds by heating to 90 ◦C for 4min to dena-
ture any secondary structure in the sample oligonucleotides. Afterwards, the
probes are slowly cooled down 1 ◦Cs−1 to ensure the efficient hybridization
of complementary strands. The dsDNA is kept at 4 ◦C until use or storage at
−20 ◦C for several months.
3.3.7 PicoGreen Intercalation Assay
Dendriplex solutions at different N/P ratios (0.6, 1, 2, 3, 5, 10, and 20) were pre-
pared as described in subsection 3.3.5 using 1mg of DNA (plasmid pmaxGFP
4.7 kbp, 20, 38, 62 and 83 base-pair double stranded oligonucleotides) and an
adequate amount of labelled (Np4Atto550) as well as unlabelled Np4 peptide
dendrimer. Then, 200µl of PicoGreen (Moleculare Probes, Germany) reagent,
diluted in Tris-EDTA buffer (subsection 3.1.5), was added and the mixture
was incubated for 5min at room temperature. Three independent experiments
were performed. PicoGreen fluorescence was measured using a Varian Cary
Eclipce Fluorescence Spectrophotometer (ex.488 nm, em. 520 nm).
3.3.8 Trypan Blue Exclusion Assays
Trypan blue exclusion assays were performed to determine the cytotoxicity
of the peptide dendrimers and the endocytosis inhibitors used by the uptake
and intracellular trafficking studies of the peptide dendriplexes in NIH3T3
EpoR and HeLa cells.
Peptide Dendrimers Cytotoxicity
The cell toxicity of the labelled (Np4Atto550) and the unlabelled peptide den-
drimer (Np4) to NIH3T3 EpoR and HeLa cells was investigated by the Trypan
Blue exclusion assay. The cells (NIH3T3 EpoR and HeLa) were grown in cul-
ture medium and seeded on six-well plates in a density of 4.104 cells/ml. The
cells were then cultured for 48 h until the cell density achieved 80%. Den-
driplexes were prepared in double distillate water as described in section 3.3
for six different N/P ratios (0.6, 1, 5, 10, 50 and 100) and added to the cells.
At the time of transfection, the medium was replaced by 2ml per well serum
reduced OPTIMEM transfection media (Live Technologies, Germany). The
dendriplexes were mixed with OPTIMEM in a total volume of 1ml and were
incubated with the cells for 4 h respectively 3 h for the HeLa cell line and then
removed. The cells were washed twice with Phosphate Buffered Saline (PBS)
subsection 3.1.5 and afterwards trypsinized (TrypLE Enzyme, Live Technolo-
gies, Germany), centrifuged for 5min at 3000rpm (AllegraX-12 Centrifuge,
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Beckman Coulter, Germany) and the supernatant was removed. The cell pel-
let was then resuspended in 200µl of PBS and mixed with the same volume
of 0.4% Trypan Blue solution (Sigama-Aldrich, Germany) and incubate for
5min at room temperature. The number of cells (viable and not viable) was
determinate by using a Neubauer cell counting chamber (Neubauer counting
chamber improved, bright-lined, Carl Roth GmbH, Germany). The addition
Figure 3.5: Trypan Blue Exclusion Assay.
of Trypan blue helps to distinguish viable, unstained cells from non-viable,
blue-stained cells (Figure 3.5). The percentage of viable cells was calculate by
the following equation:
viable cells(%) = total number of viable cells per ml of aliquot
total number of cells per ml of aliquot
x 100
(3.3)
Endocytosis Inhibitors Cytotoxicity
Seven chemical drugs (Chlorpromazine, CytochalasinD, Dynasore, Latrun-
culinA, Methyl-β-cyclodextrine, Nocodazole and Phenyl-arsine-oxide all pur-
chased from Sigma-Aldrich, Germany) known to inhibit endocytosis were
tested for their cell toxicity by the Trypan blue exclusion assay. The inhibitors
were prepared and tested at a following concentration ranges Table 3.7. HeLa
cells were seeded on 6-well plates in a density of 2.104 cells/ml andmaintained
in normal growmedium for 48 h at 37° to allow a confluence of approximately
80%. The cells were washed twice with Phosphate Buffered Saline (PBS) sub-
section 3.1.5 and 1ml of fresh OPTIMEM serum reduced transfection medium
containing the chosen inhibitors at the concentrations mentioned above was
added to each well. After incubation of 2 h at 37°, the inhibitor solutions were
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Inhibitor Tested Concentration Stock Solution
Chlorpromazine 14µm, 20µm, 25µm 25µm in water
CytochalasinD 1µm, 4µm, 10µm 1mm in DMSO
Dynasore 80µm, 100µm, 160µm 15mm in DMSO
LatrunculinA 1µm, 5µm, 10µm 500µm in water
Metyl-beta-cyclodextrine 1mm, 4mm, 10mm 20mm in water
Nocodazole 20µm, 30µm, 60µm 15mm in DMSO
Phenyl-arsine oxide 1µm, 5µm, 10µm 10mm in water
Table 3.7: Concentration ranges of the tested endocytosis inhibitors.
removed, the cells were washed twice with PBS and trypsinized (TrypLE
Enzyme, Live Technologies, Germany. Afterwards the cell mixture was cen-
trifuged (Heraeus, Thermo Scientific, Germany) for 5min at 1000rpm and the
supernatant was discarded. The cell pellet was resuspended in 300µl of PBS,
mixed with the same volume of 0.4% Trypan Blue solution and incubated for
5min at room temperature. The number of cells (viable and not viable) was
determined by using a neubauer cell counting chamber (Neubauer counting
chamber improved, bright-lined, Carl Roth GmbH, Germany). The addition
of Trypan blue helps to distinguish viable, unstained cells from non-viable,
blue-stained cells. The percentage of viable cells was calculated by means of
((3.3)).
3.3.9 Dendriplex Uptake Studies
The dendriplex uptake studies in this work have been done by using HeLa cells
and applying five of the endocytosis inhibitors tested above. The concentration
ranges for all this endocytosis inhibitors are represented in Table 3.8.
Inhibitor Applied Concentration
Chlorpromazine 14µm, 20µm, 25µm
CytochalasinD 4µm, 10µm
Dynasore 80µm, 160µm
Metyl-beta-cyclodextrine 1mm, 4mm, 10mm
Nocodazole 30µm, 60µm
Table 3.8: Endocytosis Inhibitors for Dendriplex Uptake Studies
For the dendriplex cellular uptake studies HeLa cells were cultured in
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normal gown medium as described in section 3.2. Cells were seeded on an
IBIDI µ-Slide with 8 wells at a density of 2.104 cells/well and maintained in
normal grow medium for 48 h at 37° to allow attachment and a confluence
about 80%. Cells were washed with 300µl Phosphate Buffered Saline (PBS)
and pretreated with the required amount endocytosis inhibitor (Table 3.8) in
300µl of OPTIMEM serum reduced medium for 30min at 37°. Dendriplexes
were prepared as describe in subsection 3.3.5 and then added to the cells in the
presents of the inhibitor for two hour at 37°. Afterwards the cells were washed
twice with PBS and 200µl of Leibovitz L-15 (Live Technologies, Germany) was
added. The inhibition of the dendriplex cell entry was determined by SP5X
laser scanning microscope (section 3.6) and quantified using ImageJ software
(section 3.7).
3.3.10 Mitochondria Staining
MitoTracker® Deep Red FM (Life Technologies, Germany) cell membrane-
permeant probes containing thiol-reactive choromethyl moiety was used for
staining mitochondria in HeLa cells [Cha11]. This reagent passively diffuses
across the plasma membrane and cumulates in active mitochondria. For the
mitochondria stainingHeLa cellswere cultured as described in subsection 3.2.1.
One day before the staining cells were seeded on IBIDI µ-Slide with 8 wells
in a density of 2.104 cells/well and maintained in normal grow medium at
37 ◦C to allow attachment an a confluence about 80%. Prior to mitochondria
staining experiments cells were washed twice with 300µl Phosphate Buffered
Saline (PBS) subsection 3.1.5. 20µl MitoTracker® Deep Red FM (stock solution
1µm in DMSO) diluted in 200µl of OPTIMEM serum reduced medium (end
concentration of MitoTracker® Deep Red FM 100 nm have to be kept as low
as possible because at higher concentrations, these probes tend to stain other
cellular structures) [Poo+96] was then added to the cells and incubate for
30min at 37 ◦C. Afterwards, cells were washed for 5min at 37 ◦C with fresh
grow medium to allow unbound dye to diffuse into the medium. 200µl of
Leibovitz L-15 imaging medium (Live Technologies, Germany) was added and
the mitochondria staining was determined by SP5X laser scanning microscope
section 3.6 (MitoTracker®Deep Red FM, ex.644 nm, em. 665 nm) and analysed
using the ImageJ software section 3.7.
3.3.11 Lysosomes Staining
In order to investigate the intracellular trafficking of the peptide dendriplexes
in HeLa cells a LysoTracker® Green DND-26 (Life Technologies, Germany)
reagent was used to selectively staining of the lysosomes. For this purpose
HeLa cells were cultured as described in subsection 3.2.1. One day before
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staining cells were seeded on IBIDI µ-Slide with 8 wells in a density of 2.104
cells/well and maintained in normal grow medium at 37°for 24 h to allow
attachment and confluence about 80%. Prior to lysosomes staining experi-
ments cells were washed twice with 300µl Phosphate Buffered Saline (PBS).
Then 10µl LysoTracker® Red DND-99 (stock solution 1µm in DMSO) diluted
in 200µl of OPTIMEM serum reduced medium (end concentration of the
LysoTracker® Green DND-26 100 nm have to be kept low to reduce potential
artefacts from overloading) [Cha11] was then added to te cells and incubate
for 20min at 37°. Afterwards, the loading solution was replaced with 200µl
of fresh Leibovitz L-15 imaging medium and the lysosomes staining was ob-
served by SP5X laser scanning microscope (LysoTracker® Green DND-26,
ex.490 nm, em. 511 nm) and analysed using ImageJ software.
3.3.12 Plasma Membrane Staining
CellMask™ Deep Red plasma membrane stain (Life Technologies, Germany)
was applied for the cell membrane staining inHeLa cells. This reagent provides
excellent and rapid plasma membrane staining in live cells and ample oppor-
tunities for live cell imaging [Jia+10; Hag+12]. HeLa cells were maintained
in normal grow medium as described in subsection 3.2.1. One day before
transfection cells were seeded on IBIDI µ-Slide with 8 wells (Ibidi GmbH, Mar-
tinsried, Germany) with a density of 2.104 cells/well and cultured in 300µl of
complete growmedium at 37° to allow attachment an a confluence about 80%.
Prior to plasma membrane staining cells were washed twice with PBS sub-
section 3.1.5 and 5µgml−1 (stock solution 5mgml−1 in DMSO) CellMask™
Deep Red in OPTIMEM serum reduced transfection medium was added to
the cells. After incubation for 5min at 37° the loading solution was removed
and the cells washed three times for 5min at 37°with 200µl of fresh Leibovitz
L-15 imaging medium to completely remove the unbound dye. The plasma
membrane staining was then observed by SP5X laser scanning microscope
section 3.6 (CellMask™ Deep Red, ex.649 nm, em. 666 nm) and analysed by
ImageJ software section 3.7.
3.3.13 Lipofectamine™ 2000 Transfection
Lipofectamine™ 2000 transfection reagent (Life Technologies, Germany) is a
specially designed cationic lipid which facilitate DNA and siRNA delivery
into cells [CH00]. This reagent was used as a positive control for plasmid DNA
(pmaxGFP, 4.7 kbp) delivery in to HeLa cells. Cells were maintained in normal
grow medium as described in subsection 3.2.1. One day before transfection
cell were seeded on IBIDI µ-Slide with 8 wells (Ibidi GmbH, Martinsried, Ger-
many) with a density of 2.104 cells/well an cultured in 300µl of complete
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medium without antibiotics for 24 h so that they will be 50% confluent on
the day of transfection. 50 ng of plasmid DNA (pmaxGFP) was diluted in
25µl of OPTIMEM serum reduced transfection medium and mixed gently.
1µl of Lipo f ectamineTM2000 transfection reagent was then diluted in OPTI-
MEM serum reduced medium and incubated for 5min at room temperature.
After the 5min incubation the diluted DNA was combined with the diluted
Lipo f ectamineTM2000, gently mixed by rocking the tube and incubate for at
least 25min at room temperature, then the transfection mixture was filled up
to 200µl with OPTIMEM and added to the cells. The cell were incubated for
5 h at 37 ◦C in 5% CO2. The medium was then relapsed with a fresh grow
medium containing only 5%Fetal Bovine Serum (FBS) to prevent overgrowing
and cultured for another 48 h. Afterwards, the cells were washed twice with
PBS and 200µl of Leibovitz L-15 (Life Technologies, Germany) was added.
The GFP expression was then imaged by SP5X laser scanning microscope
section 3.6 and quantified using ImageJ software section 3.7.
3.4 Plasmid DNA Transformation
The plasmid pmaxGFP (4.7 kbp) was amplified in competent Escherichia Coli
host strain, DH5α using the heat shock method. The 80µl aliquots of com-
petent cells stored at −80 ◦C were thawed at ice for 30min. 1µl of pmaxGFP
plasmid containing a total of 2 ng DNA was directly pipetted over competent
cells. These cells were mixed gently by tapping 4-5 times, incubated on ice for
15min, which was followed by a heat shock treatment (40 s at 42 ◦C). After
treatment the cells were routinely incubated on ice for 15min followed by
addition of 950µl of LB media to each vial. The vials were finally incubated
at 37 ◦C for 1 h at 300 rpm in a shaking incubator(Intors-HT Multitron, Intors
AG, Bottingen, Switzerland). The cultures were spun down for 3min at 3000
rpm (Eppendorf 5442, Eppendorf, Hamburg) and 900µl from the supernatant
was removed. 40µl of each culture was plated in triplicates on kanamycin
containing LB-agar plates. These plates were incubated at 37 ◦C overnight and
the resulting transformant colonies were grown overnight in sterile Lysogeni
Broth (LB) medium subsection 3.1.5 containing 50µgml−1 kanamycin. After-
wards, the plasmid was isolated and purified using a Qiagen Plasmid Mini
Kit (Qiagen, Germany). The isolated plasmid was then dissolved in 20µl of
sterile ultra-pure water and the concentration of plasmid DNA in solution was
determined from the UV absorbance at 260 nm using NanoDrop spectrometer
(NanoDrop™ 1000 Preqlab GmbH, Erlangen, Germany) all the measurements
were performed tree time and the average concentration was calculated.
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3.5 Instruments
Instrument Manufacturer
Laminar Flow Hera safe Thermo Electron Corporation, Ger-
many
Incubator Hera cell 150 Thermo Electron Corporation, Ger-
many
Cary Eclipce Fluorescence spec-
trophotometer
Varian, Germany
Cary Temperature Controller Varian, Germany
UV/Vis-NIR Spectrophotometer Varian, Germany
Heraeus Centrifuge Thermo Scientific, Germany
Vacuum Concentrator Eppendorf, Germany
NanoDpop-1000 Spectrometer Preqlab GmbH, Erlangen, Germany
Thermo Shaker Eppendorf, Germany
Shaking Incubator Intors AG, Bottingen, Switzerland
PCR Thermocycler PTC-100 MJ Research, Waltham, USA
Allegra X-12 Centrifuge Beckman Coulter, Germany
Table 3.9: Instruments used in this work
3.6 Fluorescent Microscope
For all the cell experiment a commercial available LEICA DMI6000B inverse
microscope with the confocal laser scanning microscopy system TCS SP5X
(Leica Microsystems GmbH, Wetzlar) and a water immersion objective (HCX
PL APO CS 63.0x/1.20 W) was used. This microscope is equipped with a
white line laser (SuperK Extreme, Koheras,Denmark) and different laser lines
between 470 nm and 670 nm can be selected with an acousto-optical beamsplit-
ter(AOBF). For observing oligonucleotide conjugated with ATTO-655, 654 nm
excitation laser line was used, and for the Np4Atto550 peptide dendrimer
excitation laser line 554 nm was used.
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3.7 Software
Name Description/Applica
tion
Provider
ImageJ 1.43 u analysis of cell and gels
images
Wayne Rasband, Na-
tional Institute of
Health, USA
Origin 8.6 data analysis for
PicoGreen measure-
ments and total cell
fluorescence calcula-
tions
ADDITIVE, Friedrichs-
dorf, Germany
LASF Live cell images data analy-
sis
Leica Microsystems
GmbH, Wetzlar, Ger-
many
Table 3.10: Software used in this work

Chapter 4
Discussion and Outlook
The developing of the gene therapy concept in the early 1990s possesses tremen-
dous potential for the successful treatment of genetically based diseases, such
as cancer. Several strategies for cancer gene therapy in vitro as well in vivo
have already been realized [Bru+03]. A major problem in exploiting the full
potential of cancer gene therapy is the lack of a safe and efficient nucleic acids
delivery system. As viral vectors are high toxic and immunogenic, non-viral
strategies are becomingmore andmore attractive. The idea of using alternative
non-viral vectors for transfer of DNA/RNA into eucaryotic cells continues
to receive a great deal of research interest. Despite the great progress in the
non viral vector development there are still a huge demand on effective and
less toxic vectors as well as insufficient understanding of their cellular entry
mechanism and trafficking.
Dendrimers have shown a great potential as non-viral delivery vectors
due to their unique architecture and ability to complex and condense nucleic
acids various sizes [Tom+85; Mam+99; MKK02]. Although, commonly used
dendrimers functionally versatile in the choice of macromolecular cargo they
still exhibit quite high cell toxicity and low transfection efficiency.
This work aimed to characterized and establish a novel class of low gen-
eration peptide dendrimers as an efficient and low toxic non-viral DNA de-
livery system. For this purpose a [8+(Arg)4-(Lys)3-(Gly)2-(Lys)-(Cys-Npys)-
Gly-NH2] (Np4) peptide dendrimer designed in the Dr. Parekh laboratory at
the Queensland University Brisbane, Australia was synthesized using the well
established solid-phase peptide synthesis (SPPS) approach. This simple and
cost effective synthesis technique facilitated the preparation of the asymmetric
dendrimers [Cha04].
For effective tracing of the pathway through the cell membrane and quan-
titative evaluation of cellular uptake the Np4 peptide dendrimer was labelled
with different fluorescent dyes. A very specific labelling was achieved by using
the p-nitro-2-pyridinesulphenyl (Npys) group.
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An interesting aspect concerning the application of the peptide dendriplexes
as a synthetic DNA delivery vectors is the mechanism of dendriplex formation
between this dendrimer and DNA various sizes as well as the complex stoi-
chiometry was then examined by electrophoretic mobility shift assay (EMSA)
as a direct technique and a PicoGreen exclusion as an indirect method.
The next important step for the characterization of the peptide dendriplex
was the investigation of their biocompatibility. To obtain information about
the in vitro toxicity of the dendriplexes, a Trypan Blue exclusion assays for two
different cell lines (NIH3T3 EpoR and HeLa cells) at different N/P ratios (the
ratios of moles of the amine groups(N) of cationic polymers to those of the
phosphate(P) ones of DNA) and DNA lengths (20 to 82 base pairs singe and
double stranded DNA as well as a plasmid DNA ) were performed.
To future investigating the relative ability of the fluorescent labelled den-
driplex to transport DNA into living cells and determine the optimal transfec-
tion charge ratio NIH 3T3 EpoR and HeLa cells were transfected with peptide
dendriplexes at different charge ratios. The optimal N/P ratio which ensure
low cytotoxicity for the both cell lines was determined to be five, whereby
HeLa cell shows higher transfection ability after a shorter incubation time.
Another important issue to be clearly define is the relationship between
DNA size and delivery efficacy. To examine the ability of the peptide den-
drimers to carry DNA different sizes into living cells (two different cell lines
were examined) the optimal determined charge ratio and single and double
stranded DNA various length as well as a plasmid DNA were applied. The op-
timized conditions from this experiments were then used for determining the
mechanism of the cellular uptake and intracellular processing the peptide den-
driplexes by studying the effect of a set of chemical inhibitors of endocytosis
that blocked specific route of uptake. Additionally the intracellular trafficking
of the dendriplexes was investigated by colocalization studies with Mito- and
lysotracker respectively used as markers for mitochondria and lysosomes.
4.1 Complex Formation Studies
Using the Fmoc-SPPS, a simple and cost effective synthesis approach a low gen-
eration asymmetric peptide dendrimers with 4+ and 8+ head group charges
have been construct. At physiological pH the surface amino groups of these
dendrimers are protonated and therefore able to interact with different forms
of nucleic acids such as DNA, RNA and oligonucleotides [ACN10]. The in-
teraction of the dendrimers with the nucleic acid is based on electrostatic
interactions between the positively charged amino groups of the dendrimer
and the negatively charged phosphate of the DNA.
The characterization of the dendrimer/DNA complex (dendriplex) is an in-
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teresting and very important aspect concerning the application of the peptide
dendrimers as a synthetic gene vectors. The complex formation between pep-
tide dendrimers and nucleic acids with different size and at different charge
ratios was determined by gel electrophoresis mobility shift assay (EMSA) and
PicoGreen exclusion assay.
Lowgeneration asymmetric peptide dendrimers are able to form complexes
(so called dendriplexes)withDNAdifferent length. The 8+ head group charged
peptide dendrimers completely retarded the plasmid DNA migration even by
lower charge ratios (N/P ratio of 1) on the other hand the lower generation
4+ peptide dendrimers appeared not to inhibit the DNA migration even by
applying higher charge ratios of 10. Complex formation between peptide
dendrimers and shorter DNA oligonucleotides could not be detected by EMSA
due to the lower resolution of the complex to the free nucleic acid and the
insufficient stability od the dendriplex within the gel matrix.
The relative fluorescence decrease of PicoGreen reach a plateau near zero
at around a charge ratio of five which indicates approximately full DNA com-
plexation for all the DNA sizes for both the labelled as well as the unlabelled
Np4 peptide dendrimers. Dendrimers bind to DNA sufficiently strongly that
they cannot be displaced by PicoGreen. At a charge ratio of three almost 90%
of the DNA is bound in dendriplexes. Completely DNA complexation were
observed at a charge ratio of 10.
4.2 Cell Experiments
Various type of cationic molecules such as cationic lipids, polylysines, chitosan
and different kind of dendrimers (PAMAM,PEI), have been employed as a
non-viral vectors for DNA transfer into eucaryotic cells [HS93; ZH94; PLS96;
Wol+96]. These diverse materials have the ability to interact with the DNA
molecules and form condensed structures which can be internalized into the
cell [SKL92; BKB97].
Dendrimers are an interesting and very promising class of high branched,
spherical cationic polymers [TNG90; Fre94]. The use of dendrimers as gene
transfection agents and drug delivery devices has been extensively reviewed
[LF99; BH04; Dut+10]. Although, amino-terminated PAMAM and PEI den-
drimers are widely used as a non-viral gene delivery systems they posses
relatively high cell toxicity attributed to the number of terminal amino groups
and the positive charge density [Mal+00; Dut+06].
In alternative to commercially available PAMAM dendrimers an asym-
metric low generation peptide based dendrimer was applied as a non-viral
vector for DNA delivery. This novel class of peptide based dendrimers are
thought to exhibit minimal toxicity and effectively complexed DNA [SSP11]. I
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applied dendrimers with significantly lower head group charges, i.e. 4+ and
8+, because dendrimers possessing large numbers of amine groups (> 32) on
their surface have been shown to be highly cytotoxic [RBZ96]. The biocompati-
bility and cell toxicity of the Np4 peptide dendrimer was investigated in two
different cell lines (NIH3T3 EpoR and HeLa) by Trypan Blue exclusion assay.
Relatively low cytotoxicity at a charge ratios (the ratios of moles of the amine
groups(N) of cationic polymers to those of the phosphate(P) ones of DNA)
ranging from 0 to 100 was determined in both cell lines for dendriplexes with
plasmid DNA and shorter (up to 40 base ss and ds DNA) oligonucleotides.
Dendriplexes formed with larger oligonucleotides (62 and 83 base ss as well
as ds DNA) have shown remarkable toxicity. A possible explanation could be
the partially complex formation leading to presents of free dendrimers and
therefore a high density of positive charge. Toxicity was observed to increase
with increasing positive charge density (N/P ratio), confirming that a high
concentration of cationic amines damages the cell membranes.
The influence of the N/P ratio on the transfection efficiency is a critical
factor for using the peptide based dendrimers as DNA delivery vectors due
to the necessity keeping the total positive charge density and the related cell
toxicity as low as possible. The optimal charge ratios conditions were estimated
for unlabelled and fluorescent labelled Np4 peptide dendrimer in NIH3T3
EpoR and HeLa cells. Applying lower N/P ratio (0.6 and 1) leads to formation
of a negatively charged or neutral dendriplexes. Having in mind that the
plasma membrane is negatively charged the interaction with dendriplexes will
becomedifficult or impossible. Thereforewe did not observeDNAdelivery into
the cells which can logically be linked to the absence of dendriplex interaction
with the cell membrane. With increasing the N/P ratio the complex is more
positively charged and the cell entry is facilitated. We detected a noticeable
increase of the total cell fluorescence at a charge ratio of two. Unlabelled
peptide dendrimer shows significantly lower transfection efficiency in both cell
lines compared to fluorescent labelled which leads to the conclusion that the
attached organic fluorophore plays an favourable role. A possible explanation
can be find in the fact that the attached fluorophore is an derivative of the well
known Rhodamine 6G which have the ability to easily enter the cell by passive
diffusion [SLG03; For+12]. Highly positively charged dendriplexes promote the
binding to the negatively charged plasma membrane and therefore facilitate
the cellular uptake but causes a higher cell mortality. Optimal transfection
(maximal transfection efficiency by moderate cytotoxicity) was determined
at N/P ratio of 5 although a charge ratio of 10 was suitable as well. In most
cells, transfection seems to be limited by the entry of dendriplex into the cell,
and efficient transfection therefore requires the use of dendriplexes with high
positive surface charge density, possibly to trigger endocytosis.
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The cell nature plays as well an important role: HeLa cells are much easier
to transfect compared to NIH3T3 EpoR cells. Comparing the total cell fluores-
cence of both cell lines it should be noted that the HeLa cells show a higher
fluorescence signal than NIH3T3 EpoR cells at the same charge ratio. The incu-
bation time for this cell line was around an hour shorter compared to NIH3T3
EpoR cell lines. Differences in the transfection ability due to the cell nature
have been noted for cationic lipids [Beh94; Fei+10], but the reason for this
differences was not fully understood. A possible reason might be the different
cellular metabolism of the dendrimer/DNA complex by different cell types.
The size of the genetic material which peptide dendrimers can transport
into the cell is a contributing factor in their application as a gene delivery
vectors. After determining the optimal transfection charge ratio the next im-
portant step was the determination of the size limitation of the DNA which
peptide dendrimers can transport across the plasma membrane. The fluores-
cent labelled peptide dendrimer was found to be able to complex and transport
single stranded DNA (ssDNA) with a size up to 83 bases in to living mouse
fibroblast and human cervix carcinoma cells. Double stranded DNA (dsDNA)
can be transported across the cell membrane with a limitation of 40 base pairs.
The limitation is based on the higher positive charge density by applying
larger DNA and the associated high cytotoxicity. Less DNA were transferred
into the cells with increasing the length of the DNA and applying double
stranded DNA, which leads to the conclusion that the complex size influence
the cellular uptake and therefore smaller single stranded DNA is more easily
taken up by the cells as larger double stranded DNA. In all the performed
experiments we observed dendriplex distribution in near to 100% of all the
cells. The intracellular distribution of the peptide dendriplexes was limited
only to the cytoplasm. A nuclear distributionwas not observedwhich indicates
of insufficient endosomal escape or/and low nuclear targeting of the peptide
dendriplexes.
The fundamental understanding of the cellular uptake and intracellular
processing of the peptide dendriplexes is a key aspect in their application as
efficient vectors for DNA delivery. The majority of reports about cell entry
mechanism of dendriplexes suggest that energy dependent endocytosis is the
most preferred route [CS03; Qi+10]. In order to dissect the possible uptake
mechanism of the peptide dendriplexes, drugs known to inhibit specific routes
of uptake were used.
Peptide dendriplexes show a remarkable reduction in cellular uptake in
the presence of chlorpromazine, dynasore and nocodazole, suggesting the
involvement of both clathrin-dependent and clathrin-independent endocytosis
pathways in the dendriplex cell entry mechanism. The greatest reduction in
the dendriplex uptake was determined in the presence of dynasore, a selective
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chemical inhibitor of dynamin, a protein essential for vesicle pinching from
the plasma membrane during clathrin-mediated endocytosis. The significant
decrease in uptake of dendriplexes in the presence of dynasore confirms the
endocytosis by dynamin-dependent pathways. In contrast, dendriplexes do
not show a reduced uptake in the presence of cytochalasin D and a negligibly
low reduction in the presence of methyl-β-cyclodextrin, which leads to the
conclusion that the actin cytoskeleton and lipid rafts/caveolae are not involved
in the cellular uptake mechanism.
In addition to determining the cellular uptake mechanism, the intracel-
lular trafficking of the peptide dendriplexes in human carcinoma cells using
lysosomes and mitochondria markers was investigated.
Due to their low pH (between 5.5-6.5) fluorescent peptide dendriplexes
are mainly localized into the lysosomes and partially into the mitochondria.
Pearson’s correlation coefficient and overlap coefficient for the lysosomes colo-
calization have higher values as this for the mitochondria.
Chapter 5
Conclusion
In conclusion, this work demonstrate that using a Fmoc-based solid-phase
peptide synthesis approach low generation asymmetric peptide dendrimers
can be easily synthesized.
The obtained results indicated that this novel class of peptide dendrimers
offer many advantages such as low cytotoxicity (this asymmetric dendrimers
will be degraded to natural amino acids, whereas PAMAM dendrimers upon
degradation may form toxic metacrylate), effective complexation of DNA and
can be successfully applied for efficient in vitro transfer of genetic material into
mammalian cells.
Fluorescent peptide dendriplexes are able to successfully carry DNA dif-
ferent sizes in to living mammalian cells. Their intracellular distribution was
limited to the cytoplasm. A nuclear distribution was not observed which in-
dicates of insufficient endosomal escape or/and low nuclear targeting of the
peptide dendriplexes. Therefore an improvement of the endosomal release and
nuclear targeting of this dendriplexes is urgently needed. Otherwise this may
results in a bottleneck regarding the application of the peptide dendrimers as
a non-viral gene delivery vectors for gene therapy.
It was shown that the uptake of peptide dendriplexes is energy dependent
and involves dynamin and microtubules, on the other hand the disassembly of
the actin cytoskeleton does not inhibit their cellular entry. Clathrin-coated pits
play an major role in the uptake of positively charged peptide dendriplexes.
Microtubules are found to be as well involved in the peptide dendriplexes
uptake. This agrees with Dausent et al. [Dau+08] who reported that uptake of
positively charged polystyrene nano particles by HeLa cells was microtubules
dependent. The question about the role of lipid raft could not be unambigu-
ously answered by these studies as the uptake was largely independent of
cholesterol depletion, but this is not a very specific inhibition for lipid raft-
dependent endocytosis because the clathrin pathway and macropinocytosis
may also be deranged.
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Low generation asymmetric peptide dendriplexes are a novel dendrimer
family that can be suitable modified and double-functionalized. The attach-
ment of a fluorophore and a peptide that target specific organelles in the cell
and exhibit high nuclear internalization can turn the peptide dendrimers based
vectors to a highly desirable system for efficient and safe DNA delivery in vivo.
Appendix A
Supporting Figures
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FigureA.1: PAGE images showing the full complexation between fluorescent la-
belled Np4Atto550 peptide dendrimer and a fluorescent labelled 83 base pairs
double stranded oligonucleotide (HXXLAtto655) at seven different high charge
ratios. Lines 1 to 7 N/P ratios 50, 100, 150, 200, 300, 400 and 500 respectively.
(a) (b)
Figure A.2: Toxicity of Np4Atto550 peptide dendriplex to NIH3T3 EpoR (blue
colour) and HeLa (red colour) cells. Controls are untreated cells (control) and
cells incubated with fluorescent labelled DNA only (DNA). (a) Np4Atto550-
OAtto655 peptide dendriplex (OAtto655 20 base single stranded DNA), (b)
Np4Atto550-HOAtto655 (HOAtto655 20 base pair double stranded DNA). Val-
ues represent means from three replicates ±SD.
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(a) (b)
Figure A.3: Toxicity of Np4Atto550 peptide dendriplex to NIH3T3 EpoR (blue
colour) and HeLa (red colour) cells. Controls are untreated cells (control) and
cells incubated with fluorescent labelled DNA only (DNA). (a) Np4Atto550-
LAtto655 peptide dendriplex (LAtto655 40 base single stranded DNA), (b)
Np4Atto550-HLAtto655 (HLAtto655 40 base pair double stranded DNA). Val-
ues represent means from three replicates ±SD.
(a) (b)
Figure A.4: Toxicity of Np4Atto550 peptide dendriplex to NIH3T3 EpoR (blue
colour) and HeLa (red colour) cells. Controls are untreated cells (control) and
cells incubated with fluorescent labelled DNA only (DNA). (a) Np4Atto550-
XLAtto655 peptide dendriplex (XLAtto655 62 base single stranded DNA), (b)
Np4Atto550-HXLAtto655 (HXLAtto655 62 base pair double stranded DNA).
Values represent means from three replicates ±SD.
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(a) (b)
Figure A.5: Toxicity of Np4Atto550 peptide dendriplex to NIH3T3 EpoR (blue
colour) and HeLa (red colour) cells. Controls are untreated cells (control) and
cells incubated with fluorescent labelled DNA only (DNA). (a) Np4Atto550-
XXLAtto655 peptide dendriplex (XXLAtto655 83 base single stranded DNA),
(b) Np4Atto550-HXXLAtto655 (HOXXLAtto655 83 base pair double stranded
DNA). Values represent means from three replicates ±SD.
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(a) (b)
Figure A.6: PicoGreen fluorescence decreasing by complex formation at differ-
ent N/P ratios (0.6, 1, 2, 3, 5, 10 and 20 respectively) between unlabelled Np4
peptide dendrimer and:(a) Double stranded 20bp oligonucleotide labelled
with Atto655 (HOAtto655), (b) Double stranded 38bp oligonucleotide labelled
with Atto655 (HLAtto655).
(a) (b)
Figure A.7: PicoGreen fluorescence decreasing by complex formation at differ-
ent N/P ratios (0.6, 1, 2, 3, 5, 10 and 20 respectively) between unlabelled Np4
peptide dendrimer and: (a) Double stranded 62bp oligonucleotide labelled
with Atto655 (HXLAtto655), (b) Double stranded 83bp oligonucleotide labelled
with Atto655 (HXXLAtto655).
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(a) (b)
Figure A.8: PicoGreen fluorescence decreasing by complex formation at differ-
ent N/P ratios (0.6, 1, 2, 3, 5, 10 and 20 respectively) between fluorescent la-
belled Np4Atto550 peptide dendrimer and: (a) Double stranded 20bp oligonu-
cleotide labelled with Atto655 (HOAtto655), (b) Double stranded 38bp oligonu-
cleotide labelled with Atto655 (HLAtto655).
(a) (b)
Figure A.9: PicoGreen fluorescence decreasing by complex formation at dif-
ferent N/P ratios (0.6, 1, 2, 3, 5, 10 and 20 respectively) between fluores-
cent labelled Np4Atto550 peptide dendrimer and: (a) Double stranded 62bp
oligonucleotide labelledwith Atto655 (HXLAtto655), (b) Double stranded 83bp
oligonucleotide labelled with Atto655 (HXXLAtto655).
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Figure A.10: The transfection efficiency of the Np4Atto550 peptide dendrimer
by NIH3T3 EpoR cells strongly depends on the charge ratio. A 20 base single
stranded DNA/Oligonucleotide labelled with Atto655 in a concentration of
200 nm was used. Green channel Np4Atto550 signal, Red channel OATTO655
signal. N/P ratios 0.6, 1, 2, 5 and 10 respectively images A to E. The scale bar
corresponds to 15µm.
114 APPENDIX A. SUPPORTING FIGURES
Figure A.11: The transfection efficiency of the unlabelled Np4 peptide den-
drimer by NIH3T3 EpoR cells is significantly low compared to fluorescent
labelled Np4 peptide dendrimer and strongly depends on the charge ratio.
A 20 base single stranded DNA/Oligonucleotide labelled with Atto655 in a
concentration of 200 nmwas used. Left side transmitted light image, right side
OAtto655 signal. N/P ratios 0.6, 5, 10, 20 and 50 respectively images A to E.
The scale bar corresponds to 15µm.
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Figure A.12: The transfection efficiency of the Np4Atto550 peptide den-
driplexes by NIH3T3 EpoR cells greatly depends on at the DNA size. All
the experiments were performed at the best condition determined in (subsec-
tion 2.4.2) with a N/P ratio of 5 by using a 20, 38, 62 and 83 base single stranded
DNA at a concentration of 200 nm images A to D. The scale bar corresponds to
15µm.
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Figure A.13: The transfection efficiency of the Np4Atto550 peptide den-
driplexes by NIH3T3 EpoR cells is as well clearly dependant on at the dsDNA
size. All the experiments were performed at the best condition determined
in (subsection 2.4.2) with a N/P ratio of 5 by using a 20 and 40 base pairs
double stranded DNA at a concentration of 200 nm. The scale bar corresponds
to 15µm.
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Figure A.14: Charge ratio dependency of the transfection efficiency by HeLa
cells using Np4 peptide dendrimer labelled with Atto550 (Np4Atto550) and
20 base ssDNA labelled with Atto655 (OAtto655) in a concentration of 200 nm.
Green channel Np4Atto550 signal, Red channel OAttO655 signal. N/P ratios
0.6, 1, 2, 5 and 10 in the images A to E. The scale bar corresponds to 15µm.
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Figure A.15: The transfection efficiency of the fluorescent labelled Np4Atto550
peptide dendrimer by HeLa cells is even dependant on the ssDNA size. All the
experiments were performed at the condition determined in (subsection 2.4.2)
with a N/P ratio of five. Images A) to D) represent the transfection with 20, 38,
62 and 83 base ssDNA. Incubation time 3 h and DNA concentration 200 nm.
The scale bar corresponds to 15µm.
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Figure A.16: The transfection efficiency of the Np4Atto550 peptide dendrimer
byHeLa cells is aswell dependant on the dsDNA size. All the experimentswere
performed at the best condition determined in (subsection 2.4.2) with a N/P
ratio of 5. A) 20 base pairs dsDNA, B) 40 base pairs ds DNA. Incubation time
3 h and a DNA concentration of 200 nmwas applied. The scale bar corresponds
to 15µm.
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Figure A.17: NIH3T3 EpoR cells incubated with fluorescent labelled dsDNA-
Atto655 various sizes in a concentration of 200 nm. Incubation time 4 h at 37 ◦C.
dsDNA size 20, 38, 62 and 83 base pair respectively images B to E. Image A only
Atto655 fluorescent dye a concentration of 200 nm. The scale bar corresponds
to 15µm
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Figure A.18: NIH3T3 EpoR cells incubated with fluorescent labelled dsDNA-
Atto655 various sizes in a concentration of 200 nm. Incubation time 4 h at 37 ◦C.
dsDNA size 20, 38, 62 and 83 base pair respectively images A to D. The scale
bar corresponds to 15µm.
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Figure A.19: HeLa cells incubated with fluorescent labelled ssDNA-Atto655
various sizes in a concentration of 200 nm. Incubation time 3 h at 37 ◦C. ssDNA
size 20, 38, 62 and 83 base pair respectively images A to D. The scale bar
corresponds to 15µm.
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Figure A.20: HeLa cells incubated with fluorescent labelled dsDNA-Atto655
various sizes in a concentration of 200 nm. Incubation time 3 h at 37 ◦C. dsDNA
size 20, 38, 62 and 83 base pair respectively images A to D. The scale bar
corresponds to 15µm.
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Figure A.21: Reduced intracellular uptake of Np4Atto550-pmaxGFP den-
driplex in HeLa cells after chlorpromazine treatment. A) Negative control-
no inhibitor, B) 14µm Chlorpromazine, C) 20µm Chlorpromazine, D) 25µm
Chlorpromazine. The cell membranes were stained with CellMask Deep Red
corresponds to the red channel. The green channel represents the fluorescent
dendriplex. Scale bars 15µm.
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Figure A.22: Effect of dynasore on the uptake of fluorescent Np4 dendriplex. A)
Negative control means no inhibitor, B) 80µm Dynasore, C) 160µm Dynasore.
The cell membranes were stained with CellMask Deep Red corresponds to
the red channel. The green channel represents the fluorescent dendriplex
(Np4Atto550-pmaxGFP). Scale bar corresponds to 15µm.
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Figure A.23: The uptake of fluorescent peptide dendriplex in HeLa cells re-
mains almost unchanged after cholesterol depletion via MβCD. A) Negative
control means no inhibitor, B) 1mmMβCD, C) 4mmMβCD, D) 10mmMβCD.
The cell membranes were stained with CellMask Deep Red corresponds to
the red channel. The green channel represents the fluorescent dendriplex
(Np4Atto550-pmaxGFP). Scale bar corresponds to 15µm.
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Figure A.24: Intracellular distribution of fluorescent peptide dendriplex into
HeLa cells after inhibiting the function of F-actin by cytochalasin D. A) Neg-
ative control no inhibitor, B) 4µm cytochalasin D, C) 10µm cytochalasin D.
The cell membranes were stained with CellMask Deep Red corresponds to
the red channel. The green channel represents the fluorescent dendriplex
(Np4Atto550-pmaxGFP). Scale bar corresponds to 15µm.
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Figure A.25: Moderate reduction of the cell entry of fluorescent peptide den-
driplexes into HeLa cells after nocodazole treatment. A) Negative control no
inhibitor, B) 30µm nocodazole, C) 60µm nocodazole. The cell membranes were
stained with CellMask Deep Red corresponds to the red channel. The green
channel represents the fluorescent dendriplex (Np4Atto550-pmaxGFP). Scale
bar corresponds to 15µm.
Appendix B
Abbreviations
Arg Arginine
bp base pair
Cys Cysteine
DCM dichloromethane
Dde 1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl
DIPEA N,N-diisopropylethylamine
DNA Deoxyribonucleic acid
DMF N,N-dimethylformamide
DTNP 2,2´-dithiobis(5-nitropyridine)
DMSO dimethyl sulphoxide
ds double stranded
EDTA ethylenediamine tetraacetic acid
EMSA Electrophoretic Mobility Shift Assays
Fmoc 9-fluorenylmethoxycarbonyl
Gly Glycine
HBTU N[(1H-benzotriazol-1-yl)(diethylamino)methylene]-N-
methylmethanaminium hexafluorophosphate-N-oxide
HeLa human epithelial cervical carcinoma cells
kb kilo base pair
Lys Lysine
NIH3T3 EpoR mouse embryonic fibroblast cells expressing Erythropoietin
NHS N-Hydroxysuccinimide
N/P the ratios of moles of the amine groups(N) of cationic polymers to those
of the phosphate(P) ones of DNA
Np3 [4+ Gly-Lys(Cys-Npys)-Gly-Gly-Lys(Arg)2] peptide dendrimer
Np4 8+ Cys(Npys)Arginine [8+(Arg)4-(Lys)3-(Gly)2-(Lys)-(Cys-Npys)-Gly-
NH2] peptide dendrimer
Np4Atto550 Np4 peptide dendrimer labelled with Atto550 fluorescent dye
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Np5 [4+ Gly-Lys(Cys-Npys)-Gly-Gly-Lys(Lys)2] peptide dendrimer
Np6 [8+ Gly-Lys(Cys-Npys)-Gly-Gly-Lys(Lys)2(Lys)4] peptide dendrimer
Nyps 3-nitro-2-pyridinesulphenyl
pDNA plasmid DNA
PAGE Polyacrylamide Gel Electrophoresis Assay
PG PicoGreen
Pbf 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulphonyl
PBS Phosphate Buffered Saline
RNA Ribonucleic acid
ss single stranded
TCEP tris(2-carboxyethyl)phosphine
TEMED Tetramethylethylendiamin
TFA trifluoroacetic acid
TIPS triisopropylsilane
Tris 2-Amino-2-hydroxymethyl-propane-1,3-diol
Trt trytil
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